{
  "resourceType": "Bundle",
  "type": "collection",
  "total": 203,
  "entry": [
    {
      "resourceType": "EvidenceReport",
      "status": "draft",
      "useContext": [
        {
          "code": {
            "system": "http://terminology.hl7.org/CodeSystem/usage-context-type",
            "code": "program",
            "display": "Program"
          },
          "valueCodeableConcept": {
            "text": "Clinical Trial Results Reporter"
          }
        }
      ],
      "date": "2021-02-26 01:09:24",
      "title": "ACTT-1 Evidence Report",
      "relatedIdentifier": [
        {
          "system": "https://clinicaltrials.gov",
          "value": "NCT04280705"
        }
      ],
      "subject": {
        "characteristic": [
          {
            "code": {
              "text": "ClinicalTrials.gov entry"
            },
            "valueReference": {
              "display": "NCT04280705"
            }
          },
          {
            "code": {
              "text": "Study Report Component"
            },
            "valueReference": {
              "display": "Results"
            }
          }
        ]
      },
      "publisher": "Computable Publishing LLC",
      "contact": [
        {
          "name": "Brian S. Alper",
          "telecom": [
            {
              "system": "email",
              "value": "support@computablepublishing.com"
            }
          ]
        }
      ],
      "author": [
        {
          "name": "Joanne Dehnbostel",
          "telecom": [
            {
              "system": "email",
              "value": "jdehnbostel@computablepublishing.com"
            }
          ]
        }
      ],
      "section": [
        {
          "title": "Form Settings",
          "focus": {
            "text": "form settings"
          },
          "section": [
            {
              "title": "Unit of Measure dropdown choices",
              "focus": {
                "text": "Unit of Measure dropdown choices"
              },
              "section": [
                {
                  "title": "coded",
                  "entryClassifier": [
                    {
                      "coding": [
                        {
                          "system": "http://unitsofmeasure.org/",
                          "code": "mg/dL",
                          "display": "mg/dL"
                        }
                      ]
                    },
                    {
                      "coding": [
                        {
                          "system": "http://unitsofmeasure.org/",
                          "code": "U/L",
                          "display": "U/L"
                        }
                      ]
                    },
                    {
                      "coding": [
                        {
                          "system": "http://unitsofmeasure.org/",
                          "code": "d",
                          "display": "days"
                        }
                      ]
                    },
                    {
                      "coding": [
                        {
                          "system": "http://unitsofmeasure.org/",
                          "code": "wk",
                          "display": "weeks"
                        }
                      ]
                    },
                    {
                      "coding": [
                        {
                          "system": "http://unitsofmeasure.org/",
                          "code": "a",
                          "display": "years"
                        }
                      ]
                    },
                    {
                      "coding": [
                        {
                          "system": "http://unitsofmeasure.org/",
                          "code": "mg",
                          "display": "mg"
                        }
                      ]
                    }
                  ]
                }
              ]
            },
            {
              "title": "Unit of Time dropdown choices",
              "focus": {
                "text": "Unit of Time dropdown choices"
              },
              "section": [
                {
                  "title": "coded",
                  "entryClassifier": [
                    {
                      "coding": [
                        {
                          "system": "http://unitsofmeasure.org/",
                          "code": "d",
                          "display": "days"
                        }
                      ]
                    },
                    {
                      "coding": [
                        {
                          "system": "http://unitsofmeasure.org/",
                          "code": "wk",
                          "display": "weeks"
                        }
                      ]
                    },
                    {
                      "coding": [
                        {
                          "system": "http://unitsofmeasure.org/",
                          "code": "a",
                          "display": "years"
                        }
                      ]
                    }
                  ]
                }
              ]
            },
            {
              "title": "Default quantities",
              "focus": {
                "text": "Default quantities"
              },
              "section": [
                {
                  "title": "Baseline Measures Default Quantities",
                  "focus": {
                    "text": "Baseline Measures"
                  },
                  "section": [
                    {
                      "title": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants",
                      "focusReference": {
                        "type": "Group",
                        "identifier": {
                          "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
                        },
                        "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
                      },
                      "entryQuantity": [
                        {
                          "value": 541
                        }
                      ]
                    },
                    {
                      "title": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants",
                      "focusReference": {
                        "type": "Group",
                        "identifier": {
                          "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
                        },
                        "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
                      },
                      "entryQuantity": [
                        {
                          "value": 521
                        }
                      ]
                    }
                  ]
                },
                {
                  "title": "Outcome Measures Default Quantities",
                  "focus": {
                    "text": "Outcome Measures"
                  },
                  "section": [
                    {
                      "title": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants",
                      "focusReference": {
                        "type": "Group",
                        "identifier": {
                          "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
                        },
                        "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
                      },
                      "entryClassifier": [
                        {
                          "coding": [
                            {
                              "code": "setAsDefault"
                            }
                          ]
                        }
                      ],
                      "entryQuantity": [
                        {
                          "value": 541
                        }
                      ]
                    },
                    {
                      "title": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants",
                      "focusReference": {
                        "type": "Group",
                        "identifier": {
                          "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
                        },
                        "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
                      },
                      "entryClassifier": [
                        {
                          "coding": [
                            {
                              "code": "setAsDefault"
                            }
                          ]
                        }
                      ],
                      "entryQuantity": [
                        {
                          "value": 521
                        }
                      ]
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "title": "Evidence Variables and Groups",
          "focus": {
            "text": "Evidence Variables and Groups"
          },
          "section": [
            {
              "title": "Population Identifier",
              "focus": {
                "text": "Population Identifier"
              },
              "entryReference": [
                {
                  "type": "Group",
                  "identifier": {
                    "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
                  },
                  "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
                }
              ]
            },
            {
              "title": "Population Descriptor",
              "focus": {
                "text": "Population Descriptor"
              },
              "entryReference": [
                {
                  "type": "Group",
                  "identifier": {
                    "value": "COVID-19"
                  },
                  "display": "COVID-19"
                }
              ]
            },
            {
              "title": "Sub Populations",
              "focus": {
                "text": "Sub Populations"
              },
              "section": [
                {
                  "title": "Exposures - Trial Arms",
                  "focus": {
                    "text": "Exposures - Trial Arms"
                  },
                  "entryReference": [
                    {
                      "type": "EvidenceVariable",
                      "identifier": {
                        "value": "Remdesivir"
                      },
                      "display": "Remdesivir"
                    },
                    {
                      "type": "EvidenceVariable",
                      "identifier": {
                        "value": "Placebo"
                      },
                      "display": "Placebo"
                    }
                  ]
                },
                {
                  "title": "Groups",
                  "focus": {
                    "text": "Groups"
                  },
                  "entryReference": [
                    {
                      "type": "Group",
                      "identifier": {
                        "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
                      },
                      "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
                    },
                    {
                      "type": "Group",
                      "identifier": {
                        "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
                      },
                      "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
                    }
                  ]
                }
              ]
            },
            {
              "title": "Baseline Measures",
              "focus": {
                "text": "Baseline Measures"
              },
              "entryReference": [
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Age"
                  },
                  "display": "Age"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Age-between-18-and-65-years"
                  },
                  "display": "Age between 18 and 65 years"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Age-65-years"
                  },
                  "display": "Age >=65 years"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Male-Sex"
                  },
                  "display": "Male Sex"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Female-Sex"
                  },
                  "display": "Female Sex"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Mild-to-Moderate-Disease"
                  },
                  "display": "Mild to Moderate Disease"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Severe-Disease"
                  },
                  "display": "Severe Disease"
                }
              ]
            },
            {
              "title": "Outcome Measures",
              "focus": {
                "text": "Outcome Measures"
              },
              "entryReference": [
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Time-to-Recovery-time-from-start-28-days"
                  },
                  "display": "Time to Recovery time from start 28 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-3-time-from-start-2-days"
                  },
                  "display": "ALT-Change from Baseline at Day 3 time from start 2 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-5-time-from-start-4-days"
                  },
                  "display": "ALT-Change from Baseline at Day 5 time from start 4 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-8-time-from-start-7-days"
                  },
                  "display": "ALT-Change from Baseline at Day 8 time from start 7 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-11-time-from-start-10-days"
                  },
                  "display": "ALT-Change from Baseline at Day 11 time from start 10 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-15-time-from-start-14-days"
                  },
                  "display": "ALT-Change from Baseline at Day 15 time from start 14 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-29-time-from-start-28-days"
                  },
                  "display": "ALT-Change from Baseline at Day 29 time from start 28 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-3-time-from-start-2-days"
                  },
                  "display": "Creatinine-Change Baseline to Day 3 time from start 2 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-5-time-from-start-4-days"
                  },
                  "display": "Creatinine-Change Baseline to Day 5 time from start 4 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-8-time-from-start-7-days"
                  },
                  "display": "Creatinine-Change Baseline to Day 8 time from start 7 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-11-time-from-start-10-days"
                  },
                  "display": "Creatinine-Change Baseline to Day 11 time from start 10 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-15-time-from-start-14-days"
                  },
                  "display": "Creatinine-Change Baseline to Day 15 time from start 14 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-29-time-from-start-28-days"
                  },
                  "display": "Creatinine-Change Baseline to Day 29 time from start 28 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-1-time-from-start-0-days"
                  },
                  "display": "Death at or before study visit at Day 1 time from start 0 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-3-time-from-start-2-days"
                  },
                  "display": "Death at or before study visit at Day 3 time from start 2 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-5-time-from-start-4-days"
                  },
                  "display": "Death at or before study visit at Day 5 time from start 4 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-8-time-from-start-7-days"
                  },
                  "display": "Death at or before study visit at Day 8 time from start 7 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-11-time-from-start-10-days"
                  },
                  "display": "Death at or before study visit at Day 11 time from start 10 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-15-time-from-start-14-days"
                  },
                  "display": "Death at or before study visit at Day 15 time from start 14 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-22-time-from-start-21-days"
                  },
                  "display": "Death at or before study visit at Day 22 time from start 21 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-29-time-from-start-28-days"
                  },
                  "display": "Death at or before study visit at Day 29 time from start 28 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-1-time-from-start-0-days"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 1 time from start 0 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-3-time-from-start-2-days"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 3 time from start 2 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-5-time-from-start-4-days"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 5 time from start 4 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-8-time-from-start-7-days"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 8 time from start 7 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-11-time-from-start-10-days"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 11 time from start 10 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-15-time-from-start-14-days"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 15 time from start 14 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-22-time-from-start-21-days"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 22 time from start 21 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-29-time-from-start-28-days"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 29 time from start 28 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Adverse-Events-Grade-3-or-4-at-Day-29-time-from-start-28-days"
                  },
                  "display": "Adverse Events Grade 3 or 4 at Day 29 time from start 28 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Serious-Adverse-Events-at-Day-29-time-from-start-28-days"
                  },
                  "display": "Serious Adverse Events at Day 29 time from start 28 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Incomplete-Dosing-Due-to-Discharge-time-from-start-9-days"
                  },
                  "display": "Incomplete Dosing Due to Discharge time from start 9 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Incomplete-Dosing-Due-to-Death-time-from-start-9-days"
                  },
                  "display": "Incomplete Dosing Due to Death time from start 9 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Incomplete-Dosing-ANY-reason-time-from-start-9-days"
                  },
                  "display": "Incomplete Dosing (ANY reason) time from start 9 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Received-all-10-intended-doses-time-from-start-9-days"
                  },
                  "display": "Received all 10 intended doses time from start 9 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Duration-of-Hospitalization-ITT-time-from-start-28-days"
                  },
                  "display": "Duration of Hospitalization/ITT time from start 28 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Duration-of-Hospitalization-Survivors-time-from-start-28-days"
                  },
                  "display": "Duration of Hospitalization/Survivors time from start 28 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Duration-of-New-Ventilator-ECMO-Use-time-from-start-28-days"
                  },
                  "display": "Duration of New Ventilator/ECMO Use time from start 28 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "Duration-of-New-Ventilator-ECMO-Use-Survivors-time-from-start-28-days"
                  },
                  "display": "Duration of New Ventilator/ECMO Use (Survivors) time from start 28 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "New-Ventilator-or-ECMO-Use-time-from-start-28-days"
                  },
                  "display": "New Ventilator or ECMO Use time from start 28 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "14-day-Mortality-time-from-start-14-days"
                  },
                  "display": "14-day Mortality time from start 14 days"
                },
                {
                  "type": "EvidenceVariable",
                  "identifier": {
                    "value": "28-day-Mortality-time-from-start-28-days"
                  },
                  "display": "28-day Mortality time from start 28 days"
                }
              ]
            }
          ]
        },
        {
          "title": "Baseline Results",
          "focus": {
            "text": "Baseline Results"
          },
          "section": [
            {
              "title": "Remdesivir Baseline Results",
              "focus": {
                "text": "Remdesivir"
              },
              "entryReference": [
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Age-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Age for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Age-between-18-and-65-years-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Age between 18 and 65 years for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Age-65-years-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Age >=65 years for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Male-Sex-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Male Sex for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Female-Sex-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Female Sex for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Mild-to-Moderate-Disease-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Mild to Moderate Disease for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Severe-Disease-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Severe Disease for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                }
              ]
            },
            {
              "title": "Placebo Baseline Results",
              "focus": {
                "text": "Placebo"
              },
              "entryReference": [
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Age-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Age for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Age-between-18-and-65-years-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Age between 18 and 65 years for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Age-65-years-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Age >=65 years for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Male-Sex-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Male Sex for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Female-Sex-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Female Sex for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Mild-to-Moderate-Disease-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Mild to Moderate Disease for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Severe-Disease-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Severe Disease for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                }
              ]
            },
            {
              "title": "Total Population Baseline Results",
              "focus": {
                "text": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
              },
              "entryReference": [
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Age-for-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Age for Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Age-between-18-and-65-years-for-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Age between 18 and 65 years for Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Age-65-years-for-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Age >=65 years for Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Male-Sex-for-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Male Sex for Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Female-Sex-for-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Female Sex for Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Mild-to-Moderate-Disease-for-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Mild to Moderate Disease for Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Severe-Disease-for-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Severe Disease for Adaptive COVID-19 Treatment Trial (ACTT)"
                }
              ]
            }
          ]
        },
        {
          "title": "Outcome Results",
          "focus": {
            "text": "Outcome Results"
          },
          "section": [
            {
              "title": "Remdesivir Outcome Results",
              "focus": {
                "text": "Remdesivir"
              },
              "entryReference": [
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Time-to-Recovery-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Time to Recovery time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-3-time-from-start-2-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "ALT-Change from Baseline at Day 3 time from start 2 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-5-time-from-start-4-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "ALT-Change from Baseline at Day 5 time from start 4 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-8-time-from-start-7-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "ALT-Change from Baseline at Day 8 time from start 7 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-11-time-from-start-10-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "ALT-Change from Baseline at Day 11 time from start 10 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-15-time-from-start-14-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "ALT-Change from Baseline at Day 15 time from start 14 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-29-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "ALT-Change from Baseline at Day 29 time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-3-time-from-start-2-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Creatinine-Change Baseline to Day 3 time from start 2 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-5-time-from-start-4-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Creatinine-Change Baseline to Day 5 time from start 4 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-8-time-from-start-7-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Creatinine-Change Baseline to Day 8 time from start 7 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-11-time-from-start-10-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Creatinine-Change Baseline to Day 11 time from start 10 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-15-time-from-start-14-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Creatinine-Change Baseline to Day 15 time from start 14 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-29-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Creatinine-Change Baseline to Day 29 time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-1-time-from-start-0-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 1 time from start 0 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-3-time-from-start-2-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 3 time from start 2 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-5-time-from-start-4-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 5 time from start 4 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-8-time-from-start-7-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 8 time from start 7 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-11-time-from-start-10-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 11 time from start 10 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-15-time-from-start-14-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 15 time from start 14 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-22-time-from-start-21-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 22 time from start 21 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-29-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 29 time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-1-time-from-start-0-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 1 time from start 0 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-3-time-from-start-2-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 3 time from start 2 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-5-time-from-start-4-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 5 time from start 4 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-8-time-from-start-7-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 8 time from start 7 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-11-time-from-start-10-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 11 time from start 10 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-15-time-from-start-14-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 15 time from start 14 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-22-time-from-start-21-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 22 time from start 21 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-29-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 29 time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Adverse-Events-Grade-3-or-4-at-Day-29-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Adverse Events Grade 3 or 4 at Day 29 time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Serious-Adverse-Events-at-Day-29-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Serious Adverse Events at Day 29 time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Incomplete-Dosing-Due-to-Discharge-time-from-start-9-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Incomplete Dosing Due to Discharge time from start 9 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Incomplete-Dosing-Due-to-Death-time-from-start-9-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Incomplete Dosing Due to Death time from start 9 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Incomplete-Dosing-ANY-reason-time-from-start-9-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Incomplete Dosing (ANY reason) time from start 9 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Received-all-10-intended-doses-time-from-start-9-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Received all 10 intended doses time from start 9 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Duration-of-Hospitalization-ITT-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Duration of Hospitalization/ITT time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Duration-of-Hospitalization-Survivors-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Duration of Hospitalization/Survivors time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Duration-of-New-Ventilator-ECMO-Use-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Duration of New Ventilator/ECMO Use time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Duration-of-New-Ventilator-ECMO-Use-Survivors-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Duration of New Ventilator/ECMO Use (Survivors) time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "New-Ventilator-or-ECMO-Use-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "New Ventilator or ECMO Use time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "14-day-Mortality-time-from-start-14-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "14-day Mortality time from start 14 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "28-day-Mortality-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "28-day Mortality time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                }
              ]
            },
            {
              "title": "Placebo Outcome Results",
              "focus": {
                "text": "Placebo"
              },
              "entryReference": [
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Time-to-Recovery-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Time to Recovery time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-3-time-from-start-2-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "ALT-Change from Baseline at Day 3 time from start 2 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-5-time-from-start-4-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "ALT-Change from Baseline at Day 5 time from start 4 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-8-time-from-start-7-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "ALT-Change from Baseline at Day 8 time from start 7 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-11-time-from-start-10-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "ALT-Change from Baseline at Day 11 time from start 10 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-15-time-from-start-14-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "ALT-Change from Baseline at Day 15 time from start 14 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-29-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "ALT-Change from Baseline at Day 29 time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-3-time-from-start-2-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Creatinine-Change Baseline to Day 3 time from start 2 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-5-time-from-start-4-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Creatinine-Change Baseline to Day 5 time from start 4 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-8-time-from-start-7-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Creatinine-Change Baseline to Day 8 time from start 7 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-11-time-from-start-10-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Creatinine-Change Baseline to Day 11 time from start 10 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-15-time-from-start-14-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Creatinine-Change Baseline to Day 15 time from start 14 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-29-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Creatinine-Change Baseline to Day 29 time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-1-time-from-start-0-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 1 time from start 0 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-3-time-from-start-2-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 3 time from start 2 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-5-time-from-start-4-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 5 time from start 4 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-8-time-from-start-7-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 8 time from start 7 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-11-time-from-start-10-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 11 time from start 10 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-15-time-from-start-14-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 15 time from start 14 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-22-time-from-start-21-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 22 time from start 21 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-29-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 29 time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-1-time-from-start-0-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 1 time from start 0 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-3-time-from-start-2-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 3 time from start 2 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-5-time-from-start-4-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 5 time from start 4 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-8-time-from-start-7-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 8 time from start 7 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-11-time-from-start-10-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 11 time from start 10 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-15-time-from-start-14-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 15 time from start 14 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-22-time-from-start-21-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 22 time from start 21 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-29-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 29 time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Adverse-Events-Grade-3-or-4-at-Day-29-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Adverse Events Grade 3 or 4 at Day 29 time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Serious-Adverse-Events-at-Day-29-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Serious Adverse Events at Day 29 time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Incomplete-Dosing-Due-to-Discharge-time-from-start-9-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Incomplete Dosing Due to Discharge time from start 9 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Incomplete-Dosing-Due-to-Death-time-from-start-9-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Incomplete Dosing Due to Death time from start 9 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Incomplete-Dosing-ANY-reason-time-from-start-9-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Incomplete Dosing (ANY reason) time from start 9 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Received-all-10-intended-doses-time-from-start-9-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Received all 10 intended doses time from start 9 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Duration-of-Hospitalization-ITT-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Duration of Hospitalization/ITT time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Duration-of-Hospitalization-Survivors-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Duration of Hospitalization/Survivors time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Duration-of-New-Ventilator-ECMO-Use-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Duration of New Ventilator/ECMO Use time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Duration-of-New-Ventilator-ECMO-Use-Survivors-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Duration of New Ventilator/ECMO Use (Survivors) time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "New-Ventilator-or-ECMO-Use-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "New Ventilator or ECMO Use time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "14-day-Mortality-time-from-start-14-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "14-day Mortality time from start 14 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "28-day-Mortality-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "28-day Mortality time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)"
                }
              ]
            },
            {
              "title": "Remdesivir vs. Placebo Outcome Results",
              "focus": {
                "text": "Remdesivir vs. Placebo"
              },
              "entryReference": [
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Time-to-Recovery-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Time to Recovery time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-3-time-from-start-2-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "ALT-Change from Baseline at Day 3 time from start 2 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-5-time-from-start-4-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "ALT-Change from Baseline at Day 5 time from start 4 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-8-time-from-start-7-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "ALT-Change from Baseline at Day 8 time from start 7 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-11-time-from-start-10-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "ALT-Change from Baseline at Day 11 time from start 10 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-15-time-from-start-14-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "ALT-Change from Baseline at Day 15 time from start 14 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "ALT-Change-from-Baseline-at-Day-29-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "ALT-Change from Baseline at Day 29 time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-3-time-from-start-2-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Creatinine-Change Baseline to Day 3 time from start 2 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-5-time-from-start-4-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Creatinine-Change Baseline to Day 5 time from start 4 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-8-time-from-start-7-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Creatinine-Change Baseline to Day 8 time from start 7 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-11-time-from-start-10-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Creatinine-Change Baseline to Day 11 time from start 10 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-15-time-from-start-14-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Creatinine-Change Baseline to Day 15 time from start 14 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Creatinine-Change-Baseline-to-Day-29-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Creatinine-Change Baseline to Day 29 time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-1-time-from-start-0-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 1 time from start 0 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-3-time-from-start-2-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 3 time from start 2 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-5-time-from-start-4-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 5 time from start 4 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-8-time-from-start-7-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 8 time from start 7 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-11-time-from-start-10-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 11 time from start 10 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-15-time-from-start-14-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 15 time from start 14 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-22-time-from-start-21-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 22 time from start 21 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Death-at-or-before-study-visit-at-Day-29-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Death at or before study visit at Day 29 time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-1-time-from-start-0-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 1 time from start 0 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-3-time-from-start-2-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 3 time from start 2 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-5-time-from-start-4-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 5 time from start 4 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-8-time-from-start-7-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 8 time from start 7 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-11-time-from-start-10-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 11 time from start 10 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-15-time-from-start-14-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 15 time from start 14 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-22-time-from-start-21-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 22 time from start 21 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Invasive-Ventilation-or-ECMO-at-Day-29-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Invasive Ventilation or ECMO at Day 29 time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Adverse-Events-Grade-3-or-4-at-Day-29-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Adverse Events Grade 3 or 4 at Day 29 time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Serious-Adverse-Events-at-Day-29-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Serious Adverse Events at Day 29 time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Incomplete-Dosing-Due-to-Discharge-time-from-start-9-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Incomplete Dosing Due to Discharge time from start 9 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Incomplete-Dosing-Due-to-Death-time-from-start-9-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Incomplete Dosing Due to Death time from start 9 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Incomplete-Dosing-ANY-reason-time-from-start-9-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Incomplete Dosing (ANY reason) time from start 9 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Received-all-10-intended-doses-time-from-start-9-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Received all 10 intended doses time from start 9 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Duration-of-Hospitalization-ITT-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Duration of Hospitalization/ITT time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Duration-of-Hospitalization-Survivors-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Duration of Hospitalization/Survivors time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Duration-of-New-Ventilator-ECMO-Use-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Duration of New Ventilator/ECMO Use time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "Duration-of-New-Ventilator-ECMO-Use-Survivors-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "Duration of New Ventilator/ECMO Use (Survivors) time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "New-Ventilator-or-ECMO-Use-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "New Ventilator or ECMO Use time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "14-day-Mortality-time-from-start-14-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "14-day Mortality time from start 14 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                },
                {
                  "type": "Evidence",
                  "identifier": {
                    "value": "28-day-Mortality-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT"
                  },
                  "display": "28-day Mortality time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)"
                }
              ]
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Group",
      "id": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants",
      "type": "person",
      "actual": true,
      "name": "Adaptive COVID-19 Treatment Trial (ACTT) participants",
      "quantity": 1062,
      "characteristic": [
        {
          "code": {
            "text": "participation in research study"
          },
          "valueReference": {
            "identifier": {
              "value": "NCT04280705"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT)"
          },
          "exclude": false
        }
      ]
    },
    {
      "resourceType": "Group",
      "id": "COVID-19",
      "type": "person",
      "actual": false,
      "name": "COVID-19",
      "characteristic": [
        {
          "code": {
            "coding": [
              {
                "system": "http://snomed.info/sct",
                "code": "397669002",
                "display": "Age"
              }
            ]
          },
          "valueRange": {
            "low": {
              "value": 18,
              "unit": "years",
              "system": "http://unitsofmeasure.org/",
              "code": "a"
            },
            "high": {
              "value": 99,
              "unit": "years",
              "system": "http://unitsofmeasure.org/",
              "code": "a"
            }
          },
          "exclude": false
        },
        {
          "code": {
            "text": "sex"
          },
          "valueCodeableConcept": {
            "text": "All"
          },
          "exclude": false
        },
        {
          "code": {
            "text": "specific question"
          },
          "valueCodeableConcept": {
            "text": "Accepts Healthy Volunteers"
          },
          "exclude": true
        }
      ]
    },
    {
      "resourceType": "Group",
      "id": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants",
      "type": "person",
      "actual": true,
      "name": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants",
      "quantity": 541,
      "characteristic": [
        {
          "code": {
            "text": "participation in research study"
          },
          "valueReference": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "exclude": false
        },
        {
          "code": {
            "text": "trial arm"
          },
          "valueReference": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          },
          "exclude": false
        }
      ]
    },
    {
      "resourceType": "Group",
      "id": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants",
      "type": "person",
      "actual": true,
      "name": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants",
      "quantity": 521,
      "characteristic": [
        {
          "code": {
            "text": "participation in research study"
          },
          "valueReference": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "exclude": false
        },
        {
          "code": {
            "text": "trial arm"
          },
          "valueReference": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          },
          "exclude": false
        }
      ]
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Remdesivir",
      "name": "Remdesivir",
      "description": "200 mg of Remdesivir administered intravenously on Day 1, followed by a 100 mg once-daily maintenance dose of Remdesivir while hospitalized for up to a 10 days total course",
      "actual": true
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Placebo",
      "name": "Placebo",
      "description": "200 mg of Remdesivir placebo administered intravenously on Day 1, followed by a 100 mg once-daily maintenance dose of Remdesivir placebo while hospitalized for up to a 10 days total course",
      "actual": true
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Age",
      "name": "Age",
      "actual": true,
      "handling": "continuous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Age-between-18-and-65-years",
      "name": "Age between 18 and 65 years",
      "actual": true,
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Age-65-years",
      "name": "Age >=65 years",
      "actual": true,
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Male-Sex",
      "name": "Male Sex",
      "actual": true,
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Female-Sex",
      "name": "Female Sex",
      "actual": true,
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Mild-to-Moderate-Disease",
      "name": "Mild to Moderate Disease",
      "description": "SpO2 > 94% and respiratory rate < 24 breaths/min without supplemental oxygen",
      "actual": true,
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Severe-Disease",
      "name": "Severe Disease",
      "description": "requiring mechanical ventilation, requiring oxygen, a SpO2 = 94% on room air, or tachypnea (respiratory rate = 24 breaths/min)",
      "actual": true,
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Time-to-Recovery-time-from-start-28-days",
      "name": "Time to Recovery time from start 28 days",
      "description": "Day of recovery is defined as the first day on which the subject satisfies one of the following three categories from the ordinal scale: 1) Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care; 2) Not hospitalized, limitation on activities and/or requiring home oxygen; 3) Not hospitalized, no limitations on activities.",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 28 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 28,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "continuous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "ALT-Change-from-Baseline-at-Day-3-time-from-start-2-days",
      "name": "ALT-Change from Baseline at Day 3 time from start 2 days",
      "description": "Blood to evaluate Alanine Transaminase (ALT)  was collected at Days 1, 3, 5, 8, and 11 while participants were inpatient, and at Days 15 and 29, with the Day 1 assessment serving as baseline. Participants who had been discharged had blood collected if infection control measures allowed for in-person visits after discharge",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 2 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 2,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "continuous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "ALT-Change-from-Baseline-at-Day-5-time-from-start-4-days",
      "name": "ALT-Change from Baseline at Day 5 time from start 4 days",
      "description": "Blood to evaluate Alanine Transaminase (ALT)  was collected at Days 1, 3, 5, 8, and 11 while participants were inpatient, and at Days 15 and 29, with the Day 1 assessment serving as baseline. Participants who had been discharged had blood collected if infection control measures allowed for in-person visits after discharge",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 4 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 4,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "continuous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "ALT-Change-from-Baseline-at-Day-8-time-from-start-7-days",
      "name": "ALT-Change from Baseline at Day 8 time from start 7 days",
      "description": "Blood to evaluate Alanine Transaminase (ALT)  was collected at Days 1, 3, 5, 8, and 11 while participants were inpatient, and at Days 15 and 29, with the Day 1 assessment serving as baseline. Participants who had been discharged had blood collected if infection control measures allowed for in-person visits after discharge",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 7 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 7,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "continuous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "ALT-Change-from-Baseline-at-Day-11-time-from-start-10-days",
      "name": "ALT-Change from Baseline at Day 11 time from start 10 days",
      "description": "Blood to evaluate Alanine Transaminase (ALT)  was collected at Days 1, 3, 5, 8, and 11 while participants were inpatient, and at Days 15 and 29, with the Day 1 assessment serving as baseline. Participants who had been discharged had blood collected if infection control measures allowed for in-person visits after discharge",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 10 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 10,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "continuous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "ALT-Change-from-Baseline-at-Day-15-time-from-start-14-days",
      "name": "ALT-Change from Baseline at Day 15 time from start 14 days",
      "description": "Blood to evaluate Alanine Transaminase (ALT)  was collected at Days 1, 3, 5, 8, and 11 while participants were inpatient, and at Days 15 and 29, with the Day 1 assessment serving as baseline. Participants who had been discharged had blood collected if infection control measures allowed for in-person visits after discharge",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 14 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 14,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "continuous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "ALT-Change-from-Baseline-at-Day-29-time-from-start-28-days",
      "name": "ALT-Change from Baseline at Day 29 time from start 28 days",
      "description": "Blood to evaluate Alanine Transaminase (ALT)  was collected at Days 1, 3, 5, 8, and 11 while participants were inpatient, and at Days 15 and 29, with the Day 1 assessment serving as baseline. Participants who had been discharged had blood collected if infection control measures allowed for in-person visits after discharge",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 28 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 28,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "continuous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Creatinine-Change-Baseline-to-Day-3-time-from-start-2-days",
      "name": "Creatinine-Change Baseline to Day 3 time from start 2 days",
      "description": "Blood to evaluate serum creatinine was collected at Days 1, 3, 5, 8, and 11 while participants were inpatient, and at Days 15 and 29, with the Day 1 assessment serving as baseline. Participants who had been discharged had blood collected if infection control measures allowed for in-person visits after discharge.",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 2 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 2,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "continuous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Creatinine-Change-Baseline-to-Day-5-time-from-start-4-days",
      "name": "Creatinine-Change Baseline to Day 5 time from start 4 days",
      "description": "Blood to evaluate serum creatinine was collected at Days 1, 3, 5, 8, and 11 while participants were inpatient, and at Days 15 and 29, with the Day 1 assessment serving as baseline. Participants who had been discharged had blood collected if infection control measures allowed for in-person visits after discharge.",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 4 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 4,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "continuous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Creatinine-Change-Baseline-to-Day-8-time-from-start-7-days",
      "name": "Creatinine-Change Baseline to Day 8 time from start 7 days",
      "description": "Blood to evaluate serum creatinine was collected at Days 1, 3, 5, 8, and 11 while participants were inpatient, and at Days 15 and 29, with the Day 1 assessment serving as baseline. Participants who had been discharged had blood collected if infection control measures allowed for in-person visits after discharge.",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 7 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 7,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "continuous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Creatinine-Change-Baseline-to-Day-11-time-from-start-10-days",
      "name": "Creatinine-Change Baseline to Day 11 time from start 10 days",
      "description": "Blood to evaluate serum creatinine was collected at Days 1, 3, 5, 8, and 11 while participants were inpatient, and at Days 15 and 29, with the Day 1 assessment serving as baseline. Participants who had been discharged had blood collected if infection control measures allowed for in-person visits after discharge.",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 10 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 10,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "continuous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Creatinine-Change-Baseline-to-Day-15-time-from-start-14-days",
      "name": "Creatinine-Change Baseline to Day 15 time from start 14 days",
      "description": "Blood to evaluate serum creatinine was collected at Days 1, 3, 5, 8, and 11 while participants were inpatient, and at Days 15 and 29, with the Day 1 assessment serving as baseline. Participants who had been discharged had blood collected if infection control measures allowed for in-person visits after discharge.",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 14 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 14,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "continuous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Creatinine-Change-Baseline-to-Day-29-time-from-start-28-days",
      "name": "Creatinine-Change Baseline to Day 29 time from start 28 days",
      "description": "Blood to evaluate serum creatinine was collected at Days 1, 3, 5, 8, and 11 while participants were inpatient, and at Days 15 and 29, with the Day 1 assessment serving as baseline. Participants who had been discharged had blood collected if infection control measures allowed for in-person visits after discharge.",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 28 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 28,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "continuous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Death-at-or-before-study-visit-at-Day-1-time-from-start-0-days",
      "name": "Death at or before study visit at Day 1 time from start 0 days",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 0 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 0,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Death-at-or-before-study-visit-at-Day-3-time-from-start-2-days",
      "name": "Death at or before study visit at Day 3 time from start 2 days",
      "description": "Invasive Ventilation at Day 3Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO)",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 2 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 2,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Death-at-or-before-study-visit-at-Day-5-time-from-start-4-days",
      "name": "Death at or before study visit at Day 5 time from start 4 days",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 4 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 4,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Death-at-or-before-study-visit-at-Day-8-time-from-start-7-days",
      "name": "Death at or before study visit at Day 8 time from start 7 days",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 7 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 7,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Death-at-or-before-study-visit-at-Day-11-time-from-start-10-days",
      "name": "Death at or before study visit at Day 11 time from start 10 days",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 10 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 10,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Death-at-or-before-study-visit-at-Day-15-time-from-start-14-days",
      "name": "Death at or before study visit at Day 15 time from start 14 days",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 14 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 14,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Death-at-or-before-study-visit-at-Day-22-time-from-start-21-days",
      "name": "Death at or before study visit at Day 22 time from start 21 days",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 21 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 21,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Death-at-or-before-study-visit-at-Day-29-time-from-start-28-days",
      "name": "Death at or before study visit at Day 29 time from start 28 days",
      "description": "Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO)",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 28 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 28,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-1-time-from-start-0-days",
      "name": "Invasive Ventilation or ECMO at Day 1 time from start 0 days",
      "description": "Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO)",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 0 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 0,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-3-time-from-start-2-days",
      "name": "Invasive Ventilation or ECMO at Day 3 time from start 2 days",
      "description": "Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO)",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 2 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 2,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-5-time-from-start-4-days",
      "name": "Invasive Ventilation or ECMO at Day 5 time from start 4 days",
      "description": "Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO)",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 4 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 4,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-8-time-from-start-7-days",
      "name": "Invasive Ventilation or ECMO at Day 8 time from start 7 days",
      "description": "Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO)",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 7 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 7,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-11-time-from-start-10-days",
      "name": "Invasive Ventilation or ECMO at Day 11 time from start 10 days",
      "description": "Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO)",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 10 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 10,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-15-time-from-start-14-days",
      "name": "Invasive Ventilation or ECMO at Day 15 time from start 14 days",
      "description": "Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO)",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 14 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 14,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-22-time-from-start-21-days",
      "name": "Invasive Ventilation or ECMO at Day 22 time from start 21 days",
      "description": "Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO)",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 21 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 21,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-29-time-from-start-28-days",
      "name": "Invasive Ventilation or ECMO at Day 29 time from start 28 days",
      "description": "Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO)",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 28 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 28,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Adverse-Events-Grade-3-or-4-at-Day-29-time-from-start-28-days",
      "name": "Adverse Events Grade 3 or 4 at Day 29 time from start 28 days",
      "description": "Grade 3 AEs are defined as events that interrupt usual activities of daily living, or significantly affects clinical status, or may require intensive therapeutic intervention. Severe events are usually incapacitating. Grade 4 AEs are defined as events that are potentially life threatening",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 28 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 28,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Serious-Adverse-Events-at-Day-29-time-from-start-28-days",
      "name": "Serious Adverse Events at Day 29 time from start 28 days",
      "description": "An SAE is defined as an AE or suspected adverse reaction is considered serious if, in the view of either the investigator or the sponsor, it results in death, a life-threatening AE, inpatient hospitalization or prolongation of existing hospitalization, a persistent or significant incapacity or substantial disruption of the ability to conduct normal life functions, or a congenital anomaly/birth defect.",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 28 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 28,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Incomplete-Dosing-Due-to-Discharge-time-from-start-9-days",
      "name": "Incomplete Dosing Due to Discharge time from start 9 days",
      "description": "Participants discontinued from investigational therapeutics due to discharge before Day 10",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 9 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 9,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Incomplete-Dosing-Due-to-Death-time-from-start-9-days",
      "name": "Incomplete Dosing Due to Death time from start 9 days",
      "description": "Participants discontinued from investigational therapeutics due to death by Day 10",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 9 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 9,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Incomplete-Dosing-ANY-reason-time-from-start-9-days",
      "name": "Incomplete Dosing (ANY reason) time from start 9 days",
      "description": "Participants discontinued from Investigational Therapeutics or Received less than 10 doses",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 9 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 9,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Received-all-10-intended-doses-time-from-start-9-days",
      "name": "Received all 10 intended doses time from start 9 days",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 9 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 9,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Duration-of-Hospitalization-ITT-time-from-start-28-days",
      "name": "Duration of Hospitalization/ITT time from start 28 days",
      "description": "Duration of hospitalization including imputations for participants who died.",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 28 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 28,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "continuous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Duration-of-Hospitalization-Survivors-time-from-start-28-days",
      "name": "Duration of Hospitalization/Survivors time from start 28 days",
      "description": "Duration of hospitalization restricted to participants who did not die",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 28 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 28,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "continuous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Duration-of-New-Ventilator-ECMO-Use-time-from-start-28-days",
      "name": "Duration of New Ventilator/ECMO Use time from start 28 days",
      "description": "Duration of new ventilator or ECMO use was measured in days among participants who were not on a ventilator or ECMO at baseline including imputations for participants who died.",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 28 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 28,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "continuous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "Duration-of-New-Ventilator-ECMO-Use-Survivors-time-from-start-28-days",
      "name": "Duration of New Ventilator/ECMO Use (Survivors) time from start 28 days",
      "description": "Duration of new ventilator or ECMO use was measured in days among participants who were not on a ventilator or ECMO at baseline,  restricted to participants who did not die",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 28 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 28,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "continuous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "New-Ventilator-or-ECMO-Use-time-from-start-28-days",
      "name": "New Ventilator or ECMO Use time from start 28 days",
      "description": "Number of participants requiring new ventilator or ECMO use, not on a ventilator or ECMO at baseline",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 28 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 28,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "14-day-Mortality-time-from-start-14-days",
      "name": "14-day Mortality time from start 14 days",
      "description": "Number of deaths by Day 15",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 14 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 14,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "EvidenceVariable",
      "id": "28-day-Mortality-time-from-start-28-days",
      "name": "28-day Mortality time from start 28 days",
      "description": "Number of deaths by Day 29",
      "actual": true,
      "characteristic": [
        {
          "definitionCodeableConcept": {
            "text": "time of measurement at 28 days"
          },
          "timeFromStart": {
            "quantity": {
              "value": 28,
              "unit": "days",
              "system": "http://unitsofmeasure.org/",
              "code": "d"
            }
          }
        }
      ],
      "handling": "dichotomous"
    },
    {
      "resourceType": "Evidence",
      "id": "Age-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Age for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Age"
            },
            "display": "Age"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": 58.6,
            "unit": "years",
            "system": "http://unitsofmeasure.org/",
            "code": "a"
          },
          "sampleSize": {
            "knownDataCount": 541
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 14.6,
                "unit": "years",
                "system": "http://unitsofmeasure.org/",
                "code": "a"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Age-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Age for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Age"
            },
            "display": "Age"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": 59.2,
            "unit": "years",
            "system": "http://unitsofmeasure.org/",
            "code": "a"
          },
          "sampleSize": {
            "knownDataCount": 521
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 15.4,
                "unit": "years",
                "system": "http://unitsofmeasure.org/",
                "code": "a"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Age-for-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Age for Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Age"
            },
            "display": "Age"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": 58.89435028248588,
            "unit": "years",
            "system": "http://unitsofmeasure.org/",
            "code": "a"
          },
          "sampleSize": {
            "knownDataCount": 1062
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 14.997786000128832,
                "unit": "years",
                "system": "http://unitsofmeasure.org/",
                "code": "a"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Age-between-18-and-65-years-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Age between 18 and 65 years for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Age-between-18-and-65-years"
            },
            "display": "Age between 18 and 65 years"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.6543438077634011
          },
          "numberOfEvents": 354,
          "sampleSize": {
            "knownDataCount": 541
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Age-between-18-and-65-years-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Age between 18 and 65 years for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Age-between-18-and-65-years"
            },
            "display": "Age between 18 and 65 years"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.6218809980806143
          },
          "numberOfEvents": 324,
          "sampleSize": {
            "knownDataCount": 521
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Age-between-18-and-65-years-for-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Age between 18 and 65 years for Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Age-between-18-and-65-years"
            },
            "display": "Age between 18 and 65 years"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.6384180790960452
          },
          "numberOfEvents": 678,
          "sampleSize": {
            "knownDataCount": 1062
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Age-65-years-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Age >=65 years for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Age-65-years"
            },
            "display": "Age >=65 years"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.3456561922365989
          },
          "numberOfEvents": 187,
          "sampleSize": {
            "knownDataCount": 541
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Age-65-years-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Age >=65 years for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Age-65-years"
            },
            "display": "Age >=65 years"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.3781190019193858
          },
          "numberOfEvents": 197,
          "sampleSize": {
            "knownDataCount": 521
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Age-65-years-for-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Age >=65 years for Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Age-65-years"
            },
            "display": "Age >=65 years"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.3615819209039548
          },
          "numberOfEvents": 384,
          "sampleSize": {
            "knownDataCount": 1062
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Male-Sex-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Male Sex for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Male-Sex"
            },
            "display": "Male Sex"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.6506469500924215
          },
          "numberOfEvents": 352,
          "sampleSize": {
            "knownDataCount": 541
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Male-Sex-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Male Sex for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Male-Sex"
            },
            "display": "Male Sex"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.6372360844529751
          },
          "numberOfEvents": 332,
          "sampleSize": {
            "knownDataCount": 521
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Male-Sex-for-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Male Sex for Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Male-Sex"
            },
            "display": "Male Sex"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.6440677966101694
          },
          "numberOfEvents": 684,
          "sampleSize": {
            "knownDataCount": 1062
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Female-Sex-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Female Sex for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Female-Sex"
            },
            "display": "Female Sex"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.34935304990757854
          },
          "numberOfEvents": 189,
          "sampleSize": {
            "knownDataCount": 541
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Female-Sex-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Female Sex for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Female-Sex"
            },
            "display": "Female Sex"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.362763915547025
          },
          "numberOfEvents": 189,
          "sampleSize": {
            "knownDataCount": 521
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Female-Sex-for-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Female Sex for Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Female-Sex"
            },
            "display": "Female Sex"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.3559322033898305
          },
          "numberOfEvents": 378,
          "sampleSize": {
            "knownDataCount": 1062
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Mild-to-Moderate-Disease-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Mild to Moderate Disease for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Mild-to-Moderate-Disease"
            },
            "display": "Mild to Moderate Disease"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.10166358595194085
          },
          "numberOfEvents": 55,
          "sampleSize": {
            "knownDataCount": 541
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Mild-to-Moderate-Disease-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Mild to Moderate Disease for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Mild-to-Moderate-Disease"
            },
            "display": "Mild to Moderate Disease"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.09596928982725528
          },
          "numberOfEvents": 50,
          "sampleSize": {
            "knownDataCount": 521
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Mild-to-Moderate-Disease-for-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Mild to Moderate Disease for Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Mild-to-Moderate-Disease"
            },
            "display": "Mild to Moderate Disease"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.09887005649717515
          },
          "numberOfEvents": 105,
          "sampleSize": {
            "knownDataCount": 1062
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Severe-Disease-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Severe Disease for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Severe-Disease"
            },
            "display": "Severe Disease"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.8983364140480592
          },
          "numberOfEvents": 486,
          "sampleSize": {
            "knownDataCount": 541
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Severe-Disease-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Severe Disease for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Severe-Disease"
            },
            "display": "Severe Disease"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.9040307101727447
          },
          "numberOfEvents": 471,
          "sampleSize": {
            "knownDataCount": 521
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Severe-Disease-for-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Severe Disease for Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Severe-Disease"
            },
            "display": "Severe Disease"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.9011299435028248
          },
          "numberOfEvents": 957,
          "sampleSize": {
            "knownDataCount": 1062
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Time-to-Recovery-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Time to Recovery time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Time-to-Recovery-time-from-start-28-days"
            },
            "display": "Time to Recovery time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C28007",
                "display": "Median"
              }
            ]
          },
          "quantity": {
            "value": 10,
            "unit": "days",
            "system": "http://unitsofmeasure.org/",
            "code": "d"
          },
          "sampleSize": {
            "knownDataCount": 399
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 9,
                  "unit": "days",
                  "system": "http://unitsofmeasure.org/",
                  "code": "d"
                },
                "high": {
                  "value": 11,
                  "unit": "days",
                  "system": "http://unitsofmeasure.org/",
                  "code": "d"
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Time-to-Recovery-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Time to Recovery time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Time-to-Recovery-time-from-start-28-days"
            },
            "display": "Time to Recovery time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C28007",
                "display": "Median"
              }
            ]
          },
          "quantity": {
            "value": 15,
            "unit": "days",
            "system": "http://unitsofmeasure.org/",
            "code": "d"
          },
          "sampleSize": {
            "knownDataCount": 352
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 13,
                  "unit": "days",
                  "system": "http://unitsofmeasure.org/",
                  "code": "d"
                },
                "high": {
                  "value": 18,
                  "unit": "days",
                  "system": "http://unitsofmeasure.org/",
                  "code": "d"
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Time-to-Recovery-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Time to Recovery time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Time-to-Recovery-time-from-start-28-days"
            },
            "display": "Time to Recovery time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "absolute-MedianDiff",
                "display": "Absolute Median Difference"
              }
            ]
          },
          "quantity": {
            "value": -5,
            "unit": "days",
            "system": "http://unitsofmeasure.org/",
            "code": "d"
          },
          "sampleSize": {
            "knownDataCount": 751
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "ALT-Change-from-Baseline-at-Day-3-time-from-start-2-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "ALT-Change from Baseline at Day 3 time from start 2 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "ALT-Change-from-Baseline-at-Day-3-time-from-start-2-days"
            },
            "display": "ALT-Change from Baseline at Day 3 time from start 2 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": 2.9,
            "unit": "U/L",
            "system": "http://unitsofmeasure.org/",
            "code": "U/L"
          },
          "sampleSize": {
            "knownDataCount": 465
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 31.5,
                "unit": "U/L",
                "system": "http://unitsofmeasure.org/",
                "code": "U/L"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "ALT-Change-from-Baseline-at-Day-3-time-from-start-2-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "ALT-Change from Baseline at Day 3 time from start 2 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "ALT-Change-from-Baseline-at-Day-3-time-from-start-2-days"
            },
            "display": "ALT-Change from Baseline at Day 3 time from start 2 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": 14.3,
            "unit": "U/L",
            "system": "http://unitsofmeasure.org/",
            "code": "U/L"
          },
          "sampleSize": {
            "knownDataCount": 463
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 88,
                "unit": "U/L",
                "system": "http://unitsofmeasure.org/",
                "code": "U/L"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "ALT-Change-from-Baseline-at-Day-3-time-from-start-2-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "ALT-Change from Baseline at Day 3 time from start 2 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "ALT-Change-from-Baseline-at-Day-3-time-from-start-2-days"
            },
            "display": "ALT-Change from Baseline at Day 3 time from start 2 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000457",
                "display": "Mean Difference"
              }
            ]
          },
          "quantity": {
            "value": -11.4,
            "unit": "U/L",
            "system": "http://unitsofmeasure.org/",
            "code": "U/L"
          },
          "sampleSize": {
            "knownDataCount": 928
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "ALT-Change-from-Baseline-at-Day-5-time-from-start-4-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "ALT-Change from Baseline at Day 5 time from start 4 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "ALT-Change-from-Baseline-at-Day-5-time-from-start-4-days"
            },
            "display": "ALT-Change from Baseline at Day 5 time from start 4 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": 10.8,
            "unit": "U/L",
            "system": "http://unitsofmeasure.org/",
            "code": "U/L"
          },
          "sampleSize": {
            "knownDataCount": 398
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 55.8,
                "unit": "U/L",
                "system": "http://unitsofmeasure.org/",
                "code": "U/L"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "ALT-Change-from-Baseline-at-Day-5-time-from-start-4-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "ALT-Change from Baseline at Day 5 time from start 4 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "ALT-Change-from-Baseline-at-Day-5-time-from-start-4-days"
            },
            "display": "ALT-Change from Baseline at Day 5 time from start 4 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": 23.1,
            "unit": "U/L",
            "system": "http://unitsofmeasure.org/",
            "code": "U/L"
          },
          "sampleSize": {
            "knownDataCount": 403
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 70.6,
                "unit": "U/L",
                "system": "http://unitsofmeasure.org/",
                "code": "U/L"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "ALT-Change-from-Baseline-at-Day-5-time-from-start-4-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "ALT-Change from Baseline at Day 5 time from start 4 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "ALT-Change-from-Baseline-at-Day-5-time-from-start-4-days"
            },
            "display": "ALT-Change from Baseline at Day 5 time from start 4 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000457",
                "display": "Mean Difference"
              }
            ]
          },
          "quantity": {
            "value": -12.3,
            "unit": "U/L",
            "system": "http://unitsofmeasure.org/",
            "code": "U/L"
          },
          "sampleSize": {
            "knownDataCount": 801
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "ALT-Change-from-Baseline-at-Day-8-time-from-start-7-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "ALT-Change from Baseline at Day 8 time from start 7 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "ALT-Change-from-Baseline-at-Day-8-time-from-start-7-days"
            },
            "display": "ALT-Change from Baseline at Day 8 time from start 7 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": 8.9,
            "unit": "U/L",
            "system": "http://unitsofmeasure.org/",
            "code": "U/L"
          },
          "sampleSize": {
            "knownDataCount": 296
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 54.2,
                "unit": "U/L",
                "system": "http://unitsofmeasure.org/",
                "code": "U/L"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "ALT-Change-from-Baseline-at-Day-8-time-from-start-7-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "ALT-Change from Baseline at Day 8 time from start 7 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "ALT-Change-from-Baseline-at-Day-8-time-from-start-7-days"
            },
            "display": "ALT-Change from Baseline at Day 8 time from start 7 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": 24.2,
            "unit": "U/L",
            "system": "http://unitsofmeasure.org/",
            "code": "U/L"
          },
          "sampleSize": {
            "knownDataCount": 327
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 79.7,
                "unit": "U/L",
                "system": "http://unitsofmeasure.org/",
                "code": "U/L"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "ALT-Change-from-Baseline-at-Day-8-time-from-start-7-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "ALT-Change from Baseline at Day 8 time from start 7 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "ALT-Change-from-Baseline-at-Day-8-time-from-start-7-days"
            },
            "display": "ALT-Change from Baseline at Day 8 time from start 7 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000457",
                "display": "Mean Difference"
              }
            ]
          },
          "quantity": {
            "value": -15.299999999999999,
            "unit": "U/L",
            "system": "http://unitsofmeasure.org/",
            "code": "U/L"
          },
          "sampleSize": {
            "knownDataCount": 623
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "ALT-Change-from-Baseline-at-Day-11-time-from-start-10-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "ALT-Change from Baseline at Day 11 time from start 10 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "ALT-Change-from-Baseline-at-Day-11-time-from-start-10-days"
            },
            "display": "ALT-Change from Baseline at Day 11 time from start 10 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": 3.4,
            "unit": "U/L",
            "system": "http://unitsofmeasure.org/",
            "code": "U/L"
          },
          "sampleSize": {
            "knownDataCount": 227
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 48.4,
                "unit": "U/L",
                "system": "http://unitsofmeasure.org/",
                "code": "U/L"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "ALT-Change-from-Baseline-at-Day-11-time-from-start-10-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "ALT-Change from Baseline at Day 11 time from start 10 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "ALT-Change-from-Baseline-at-Day-11-time-from-start-10-days"
            },
            "display": "ALT-Change from Baseline at Day 11 time from start 10 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": 27.7,
            "unit": "U/L",
            "system": "http://unitsofmeasure.org/",
            "code": "U/L"
          },
          "sampleSize": {
            "knownDataCount": 257
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 89.8,
                "unit": "U/L",
                "system": "http://unitsofmeasure.org/",
                "code": "U/L"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "ALT-Change-from-Baseline-at-Day-11-time-from-start-10-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "ALT-Change from Baseline at Day 11 time from start 10 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "ALT-Change-from-Baseline-at-Day-11-time-from-start-10-days"
            },
            "display": "ALT-Change from Baseline at Day 11 time from start 10 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000457",
                "display": "Mean Difference"
              }
            ]
          },
          "quantity": {
            "value": -24.3,
            "unit": "U/L",
            "system": "http://unitsofmeasure.org/",
            "code": "U/L"
          },
          "sampleSize": {
            "knownDataCount": 484
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "ALT-Change-from-Baseline-at-Day-15-time-from-start-14-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "ALT-Change from Baseline at Day 15 time from start 14 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "ALT-Change-from-Baseline-at-Day-15-time-from-start-14-days"
            },
            "display": "ALT-Change from Baseline at Day 15 time from start 14 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": 1.7,
            "unit": "U/L",
            "system": "http://unitsofmeasure.org/",
            "code": "U/L"
          },
          "sampleSize": {
            "knownDataCount": 257
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 47.4,
                "unit": "U/L",
                "system": "http://unitsofmeasure.org/",
                "code": "U/L"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "ALT-Change-from-Baseline-at-Day-15-time-from-start-14-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "ALT-Change from Baseline at Day 15 time from start 14 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "ALT-Change-from-Baseline-at-Day-15-time-from-start-14-days"
            },
            "display": "ALT-Change from Baseline at Day 15 time from start 14 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": 28.1,
            "unit": "U/L",
            "system": "http://unitsofmeasure.org/",
            "code": "U/L"
          },
          "sampleSize": {
            "knownDataCount": 242
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 110.1,
                "unit": "U/L",
                "system": "http://unitsofmeasure.org/",
                "code": "U/L"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "ALT-Change-from-Baseline-at-Day-15-time-from-start-14-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "ALT-Change from Baseline at Day 15 time from start 14 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "ALT-Change-from-Baseline-at-Day-15-time-from-start-14-days"
            },
            "display": "ALT-Change from Baseline at Day 15 time from start 14 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000457",
                "display": "Mean Difference"
              }
            ]
          },
          "quantity": {
            "value": -26.400000000000002,
            "unit": "U/L",
            "system": "http://unitsofmeasure.org/",
            "code": "U/L"
          },
          "sampleSize": {
            "knownDataCount": 499
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "ALT-Change-from-Baseline-at-Day-29-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "ALT-Change from Baseline at Day 29 time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "ALT-Change-from-Baseline-at-Day-29-time-from-start-28-days"
            },
            "display": "ALT-Change from Baseline at Day 29 time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": -6.8,
            "unit": "U/L",
            "system": "http://unitsofmeasure.org/",
            "code": "U/L"
          },
          "sampleSize": {
            "knownDataCount": 220
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 43.7,
                "unit": "U/L",
                "system": "http://unitsofmeasure.org/",
                "code": "U/L"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "ALT-Change-from-Baseline-at-Day-29-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "ALT-Change from Baseline at Day 29 time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "ALT-Change-from-Baseline-at-Day-29-time-from-start-28-days"
            },
            "display": "ALT-Change from Baseline at Day 29 time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": -3.9,
            "unit": "U/L",
            "system": "http://unitsofmeasure.org/",
            "code": "U/L"
          },
          "sampleSize": {
            "knownDataCount": 180
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 62.2,
                "unit": "U/L",
                "system": "http://unitsofmeasure.org/",
                "code": "U/L"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "ALT-Change-from-Baseline-at-Day-29-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "ALT-Change from Baseline at Day 29 time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "ALT-Change-from-Baseline-at-Day-29-time-from-start-28-days"
            },
            "display": "ALT-Change from Baseline at Day 29 time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000457",
                "display": "Mean Difference"
              }
            ]
          },
          "quantity": {
            "value": -2.9,
            "unit": "U/L",
            "system": "http://unitsofmeasure.org/",
            "code": "U/L"
          },
          "sampleSize": {
            "knownDataCount": 400
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Creatinine-Change-Baseline-to-Day-3-time-from-start-2-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Creatinine-Change Baseline to Day 3 time from start 2 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Creatinine-Change-Baseline-to-Day-3-time-from-start-2-days"
            },
            "display": "Creatinine-Change Baseline to Day 3 time from start 2 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": 0.038,
            "unit": "mg/dL",
            "system": "http://unitsofmeasure.org/",
            "code": "mg/dL"
          },
          "sampleSize": {
            "knownDataCount": 482
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 0.569,
                "unit": "mg/dL",
                "system": "http://unitsofmeasure.org/",
                "code": "mg/dL"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Creatinine-Change-Baseline-to-Day-3-time-from-start-2-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Creatinine-Change Baseline to Day 3 time from start 2 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Creatinine-Change-Baseline-to-Day-3-time-from-start-2-days"
            },
            "display": "Creatinine-Change Baseline to Day 3 time from start 2 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": 0.037,
            "unit": "mg/dL",
            "system": "http://unitsofmeasure.org/",
            "code": "mg/dL"
          },
          "sampleSize": {
            "knownDataCount": 475
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 0.517,
                "unit": "mg/dL",
                "system": "http://unitsofmeasure.org/",
                "code": "mg/dL"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Creatinine-Change-Baseline-to-Day-3-time-from-start-2-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Creatinine-Change Baseline to Day 3 time from start 2 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Creatinine-Change-Baseline-to-Day-3-time-from-start-2-days"
            },
            "display": "Creatinine-Change Baseline to Day 3 time from start 2 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000457",
                "display": "Mean Difference"
              }
            ]
          },
          "quantity": {
            "value": 0.0010000000000000009,
            "unit": "mg/dL",
            "system": "http://unitsofmeasure.org/",
            "code": "mg/dL"
          },
          "sampleSize": {
            "knownDataCount": 957
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Creatinine-Change-Baseline-to-Day-5-time-from-start-4-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Creatinine-Change Baseline to Day 5 time from start 4 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Creatinine-Change-Baseline-to-Day-5-time-from-start-4-days"
            },
            "display": "Creatinine-Change Baseline to Day 5 time from start 4 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": 0.075,
            "unit": "mg/dL",
            "system": "http://unitsofmeasure.org/",
            "code": "mg/dL"
          },
          "sampleSize": {
            "knownDataCount": 411
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 0.762,
                "unit": "mg/dL",
                "system": "http://unitsofmeasure.org/",
                "code": "mg/dL"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Creatinine-Change-Baseline-to-Day-5-time-from-start-4-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Creatinine-Change Baseline to Day 5 time from start 4 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Creatinine-Change-Baseline-to-Day-5-time-from-start-4-days"
            },
            "display": "Creatinine-Change Baseline to Day 5 time from start 4 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": -0.695,
            "unit": "mg/dL",
            "system": "http://unitsofmeasure.org/",
            "code": "mg/dL"
          },
          "sampleSize": {
            "knownDataCount": 418
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 17.552,
                "unit": "mg/dL",
                "system": "http://unitsofmeasure.org/",
                "code": "mg/dL"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Creatinine-Change-Baseline-to-Day-5-time-from-start-4-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Creatinine-Change Baseline to Day 5 time from start 4 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Creatinine-Change-Baseline-to-Day-5-time-from-start-4-days"
            },
            "display": "Creatinine-Change Baseline to Day 5 time from start 4 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000457",
                "display": "Mean Difference"
              }
            ]
          },
          "quantity": {
            "value": 0.7699999999999999,
            "unit": "mg/dL",
            "system": "http://unitsofmeasure.org/",
            "code": "mg/dL"
          },
          "sampleSize": {
            "knownDataCount": 829
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Creatinine-Change-Baseline-to-Day-8-time-from-start-7-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Creatinine-Change Baseline to Day 8 time from start 7 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Creatinine-Change-Baseline-to-Day-8-time-from-start-7-days"
            },
            "display": "Creatinine-Change Baseline to Day 8 time from start 7 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": 0.158,
            "unit": "mg/dL",
            "system": "http://unitsofmeasure.org/",
            "code": "mg/dL"
          },
          "sampleSize": {
            "knownDataCount": 309
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 0.951,
                "unit": "mg/dL",
                "system": "http://unitsofmeasure.org/",
                "code": "mg/dL"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Creatinine-Change-Baseline-to-Day-8-time-from-start-7-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Creatinine-Change Baseline to Day 8 time from start 7 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Creatinine-Change-Baseline-to-Day-8-time-from-start-7-days"
            },
            "display": "Creatinine-Change Baseline to Day 8 time from start 7 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": -0.882,
            "unit": "mg/dL",
            "system": "http://unitsofmeasure.org/",
            "code": "mg/dL"
          },
          "sampleSize": {
            "knownDataCount": 335
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 19.637,
                "unit": "mg/dL",
                "system": "http://unitsofmeasure.org/",
                "code": "mg/dL"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Creatinine-Change-Baseline-to-Day-8-time-from-start-7-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Creatinine-Change Baseline to Day 8 time from start 7 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Creatinine-Change-Baseline-to-Day-8-time-from-start-7-days"
            },
            "display": "Creatinine-Change Baseline to Day 8 time from start 7 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000457",
                "display": "Mean Difference"
              }
            ]
          },
          "quantity": {
            "value": 1.04,
            "unit": "mg/dL",
            "system": "http://unitsofmeasure.org/",
            "code": "mg/dL"
          },
          "sampleSize": {
            "knownDataCount": 644
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Creatinine-Change-Baseline-to-Day-11-time-from-start-10-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Creatinine-Change Baseline to Day 11 time from start 10 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Creatinine-Change-Baseline-to-Day-11-time-from-start-10-days"
            },
            "display": "Creatinine-Change Baseline to Day 11 time from start 10 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": 0.236,
            "unit": "mg/dL",
            "system": "http://unitsofmeasure.org/",
            "code": "mg/dL"
          },
          "sampleSize": {
            "knownDataCount": 234
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 1.057,
                "unit": "mg/dL",
                "system": "http://unitsofmeasure.org/",
                "code": "mg/dL"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Creatinine-Change-Baseline-to-Day-11-time-from-start-10-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Creatinine-Change Baseline to Day 11 time from start 10 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Creatinine-Change-Baseline-to-Day-11-time-from-start-10-days"
            },
            "display": "Creatinine-Change Baseline to Day 11 time from start 10 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": 1.173,
            "unit": "mg/dL",
            "system": "http://unitsofmeasure.org/",
            "code": "mg/dL"
          },
          "sampleSize": {
            "knownDataCount": 269
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 15.44,
                "unit": "mg/dL",
                "system": "http://unitsofmeasure.org/",
                "code": "mg/dL"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Creatinine-Change-Baseline-to-Day-11-time-from-start-10-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Creatinine-Change Baseline to Day 11 time from start 10 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Creatinine-Change-Baseline-to-Day-11-time-from-start-10-days"
            },
            "display": "Creatinine-Change Baseline to Day 11 time from start 10 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000457",
                "display": "Mean Difference"
              }
            ]
          },
          "quantity": {
            "value": -0.937,
            "unit": "mg/dL",
            "system": "http://unitsofmeasure.org/",
            "code": "mg/dL"
          },
          "sampleSize": {
            "knownDataCount": 503
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Creatinine-Change-Baseline-to-Day-15-time-from-start-14-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Creatinine-Change Baseline to Day 15 time from start 14 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Creatinine-Change-Baseline-to-Day-15-time-from-start-14-days"
            },
            "display": "Creatinine-Change Baseline to Day 15 time from start 14 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": 0.319,
            "unit": "mg/dL",
            "system": "http://unitsofmeasure.org/",
            "code": "mg/dL"
          },
          "sampleSize": {
            "knownDataCount": 262
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 2.147,
                "unit": "mg/dL",
                "system": "http://unitsofmeasure.org/",
                "code": "mg/dL"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Creatinine-Change-Baseline-to-Day-15-time-from-start-14-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Creatinine-Change Baseline to Day 15 time from start 14 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Creatinine-Change-Baseline-to-Day-15-time-from-start-14-days"
            },
            "display": "Creatinine-Change Baseline to Day 15 time from start 14 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": -1.239,
            "unit": "mg/dL",
            "system": "http://unitsofmeasure.org/",
            "code": "mg/dL"
          },
          "sampleSize": {
            "knownDataCount": 249
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 22.755,
                "unit": "mg/dL",
                "system": "http://unitsofmeasure.org/",
                "code": "mg/dL"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Creatinine-Change-Baseline-to-Day-15-time-from-start-14-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Creatinine-Change Baseline to Day 15 time from start 14 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Creatinine-Change-Baseline-to-Day-15-time-from-start-14-days"
            },
            "display": "Creatinine-Change Baseline to Day 15 time from start 14 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000457",
                "display": "Mean Difference"
              }
            ]
          },
          "quantity": {
            "value": 1.558,
            "unit": "mg/dL",
            "system": "http://unitsofmeasure.org/",
            "code": "mg/dL"
          },
          "sampleSize": {
            "knownDataCount": 511
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Creatinine-Change-Baseline-to-Day-29-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Creatinine-Change Baseline to Day 29 time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Creatinine-Change-Baseline-to-Day-29-time-from-start-28-days"
            },
            "display": "Creatinine-Change Baseline to Day 29 time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": 0.075,
            "unit": "mg/dL",
            "system": "http://unitsofmeasure.org/",
            "code": "mg/dL"
          },
          "sampleSize": {
            "knownDataCount": 229
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 0.644,
                "unit": "mg/dL",
                "system": "http://unitsofmeasure.org/",
                "code": "mg/dL"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Creatinine-Change-Baseline-to-Day-29-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Creatinine-Change Baseline to Day 29 time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Creatinine-Change-Baseline-to-Day-29-time-from-start-28-days"
            },
            "display": "Creatinine-Change Baseline to Day 29 time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C53319",
                "display": "Mean"
              }
            ]
          },
          "quantity": {
            "value": -1.863,
            "unit": "mg/dL",
            "system": "http://unitsofmeasure.org/",
            "code": "mg/dL"
          },
          "sampleSize": {
            "knownDataCount": 189
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53322",
                    "display": "Standard deviation"
                  }
                ]
              },
              "quantity": {
                "value": 26.093,
                "unit": "mg/dL",
                "system": "http://unitsofmeasure.org/",
                "code": "mg/dL"
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Creatinine-Change-Baseline-to-Day-29-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Creatinine-Change Baseline to Day 29 time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Creatinine-Change-Baseline-to-Day-29-time-from-start-28-days"
            },
            "display": "Creatinine-Change Baseline to Day 29 time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000457",
                "display": "Mean Difference"
              }
            ]
          },
          "quantity": {
            "value": 1.938,
            "unit": "mg/dL",
            "system": "http://unitsofmeasure.org/",
            "code": "mg/dL"
          },
          "sampleSize": {
            "knownDataCount": 418
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-1-time-from-start-0-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 1 time from start 0 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-1-time-from-start-0-days"
            },
            "display": "Death at or before study visit at Day 1 time from start 0 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0
          },
          "numberOfEvents": 0,
          "sampleSize": {
            "knownDataCount": 541
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-1-time-from-start-0-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 1 time from start 0 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-1-time-from-start-0-days"
            },
            "display": "Death at or before study visit at Day 1 time from start 0 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0
          },
          "numberOfEvents": 0,
          "sampleSize": {
            "knownDataCount": 521
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-1-time-from-start-0-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 1 time from start 0 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-1-time-from-start-0-days"
            },
            "display": "Death at or before study visit at Day 1 time from start 0 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": 0
          },
          "numberOfEvents": 0,
          "sampleSize": {
            "knownDataCount": 1062
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-3-time-from-start-2-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 3 time from start 2 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-3-time-from-start-2-days"
            },
            "display": "Death at or before study visit at Day 3 time from start 2 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.005545286506469501
          },
          "numberOfEvents": 3,
          "sampleSize": {
            "knownDataCount": 541
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0
                },
                "high": {
                  "value": 0.011802946162649045
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-3-time-from-start-2-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 3 time from start 2 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-3-time-from-start-2-days"
            },
            "display": "Death at or before study visit at Day 3 time from start 2 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.013435700575815739
          },
          "numberOfEvents": 7,
          "sampleSize": {
            "knownDataCount": 521
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.0035494852369646612
                },
                "high": {
                  "value": 0.023321915914666817
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-3-time-from-start-2-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 3 time from start 2 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-3-time-from-start-2-days"
            },
            "display": "Death at or before study visit at Day 3 time from start 2 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": -0.007890414069346239
          },
          "numberOfEvents": 10,
          "sampleSize": {
            "knownDataCount": 1062
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": -0.019590651592521203
                },
                "high": {
                  "value": 0.003809823453828725
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-5-time-from-start-4-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 5 time from start 4 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-5-time-from-start-4-days"
            },
            "display": "Death at or before study visit at Day 5 time from start 4 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.02033271719038817
          },
          "numberOfEvents": 11,
          "sampleSize": {
            "knownDataCount": 541
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.008439634154575656
                },
                "high": {
                  "value": 0.03222580022620068
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-5-time-from-start-4-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 5 time from start 4 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-5-time-from-start-4-days"
            },
            "display": "Death at or before study visit at Day 5 time from start 4 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.023032629558541268
          },
          "numberOfEvents": 12,
          "sampleSize": {
            "knownDataCount": 521
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.010151646750158722
                },
                "high": {
                  "value": 0.035913612366923815
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-5-time-from-start-4-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 5 time from start 4 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-5-time-from-start-4-days"
            },
            "display": "Death at or before study visit at Day 5 time from start 4 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": -0.002699912368153097
          },
          "numberOfEvents": 23,
          "sampleSize": {
            "knownDataCount": 1062
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": -0.020231744622842798
                },
                "high": {
                  "value": 0.014831919886536604
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-8-time-from-start-7-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 8 time from start 7 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-8-time-from-start-7-days"
            },
            "display": "Death at or before study visit at Day 8 time from start 7 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.031423290203327174
          },
          "numberOfEvents": 17,
          "sampleSize": {
            "knownDataCount": 541
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.016722175101961008
                },
                "high": {
                  "value": 0.04612440530469334
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-8-time-from-start-7-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 8 time from start 7 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-8-time-from-start-7-days"
            },
            "display": "Death at or before study visit at Day 8 time from start 7 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.06525911708253358
          },
          "numberOfEvents": 34,
          "sampleSize": {
            "knownDataCount": 521
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.044050935870911884
                },
                "high": {
                  "value": 0.08646729829415528
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-8-time-from-start-7-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 8 time from start 7 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-8-time-from-start-7-days"
            },
            "display": "Death at or before study visit at Day 8 time from start 7 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": -0.03383582687920641
          },
          "numberOfEvents": 51,
          "sampleSize": {
            "knownDataCount": 1062
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": -0.05964105378246382
                },
                "high": {
                  "value": -0.008030599975948995
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-11-time-from-start-10-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 11 time from start 10 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-11-time-from-start-10-days"
            },
            "display": "Death at or before study visit at Day 11 time from start 10 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.04066543438077634
          },
          "numberOfEvents": 22,
          "sampleSize": {
            "knownDataCount": 541
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.024021530731011508
                },
                "high": {
                  "value": 0.057309338030541175
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-11-time-from-start-10-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 11 time from start 10 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-11-time-from-start-10-days"
            },
            "display": "Death at or before study visit at Day 11 time from start 10 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.07869481765834933
          },
          "numberOfEvents": 41,
          "sampleSize": {
            "knownDataCount": 521
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.05557352911956308
                },
                "high": {
                  "value": 0.10181610619713559
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-11-time-from-start-10-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 11 time from start 10 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-11-time-from-start-10-days"
            },
            "display": "Death at or before study visit at Day 11 time from start 10 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": -0.03802938327757299
          },
          "numberOfEvents": 63,
          "sampleSize": {
            "knownDataCount": 1062
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": -0.06651821463999402
                },
                "high": {
                  "value": -0.00954055191515197
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-15-time-from-start-14-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 15 time from start 14 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-15-time-from-start-14-days"
            },
            "display": "Death at or before study visit at Day 15 time from start 14 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.06284658040665435
          },
          "numberOfEvents": 34,
          "sampleSize": {
            "knownDataCount": 541
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.04239609541750307
                },
                "high": {
                  "value": 0.08329706539580563
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-15-time-from-start-14-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 15 time from start 14 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-15-time-from-start-14-days"
            },
            "display": "Death at or before study visit at Day 15 time from start 14 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.11132437619961612
          },
          "numberOfEvents": 58,
          "sampleSize": {
            "knownDataCount": 521
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.08431565768280375
                },
                "high": {
                  "value": 0.1383330947164285
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-15-time-from-start-14-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 15 time from start 14 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-15-time-from-start-14-days"
            },
            "display": "Death at or before study visit at Day 15 time from start 14 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": -0.04847779579296177
          },
          "numberOfEvents": 92,
          "sampleSize": {
            "knownDataCount": 1062
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": -0.08235541690501605
                },
                "high": {
                  "value": -0.014600174680907498
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-22-time-from-start-21-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 22 time from start 21 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-22-time-from-start-21-days"
            },
            "display": "Death at or before study visit at Day 22 time from start 21 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.09242144177449169
          },
          "numberOfEvents": 50,
          "sampleSize": {
            "knownDataCount": 541
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.06801604223142471
                },
                "high": {
                  "value": 0.11682684131755866
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-22-time-from-start-21-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 22 time from start 21 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-22-time-from-start-21-days"
            },
            "display": "Death at or before study visit at Day 22 time from start 21 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.12859884836852206
          },
          "numberOfEvents": 67,
          "sampleSize": {
            "knownDataCount": 521
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.09985368281882333
                },
                "high": {
                  "value": 0.15734401391822078
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-22-time-from-start-21-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 22 time from start 21 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-22-time-from-start-21-days"
            },
            "display": "Death at or before study visit at Day 22 time from start 21 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": -0.036177406594030376
          },
          "numberOfEvents": 117,
          "sampleSize": {
            "knownDataCount": 1062
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": -0.0738856029091065
                },
                "high": {
                  "value": 0.0015307897210457416
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-29-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 29 time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-29-time-from-start-28-days"
            },
            "display": "Death at or before study visit at Day 29 time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.10720887245841035
          },
          "numberOfEvents": 58,
          "sampleSize": {
            "knownDataCount": 541
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.08113846998380392
                },
                "high": {
                  "value": 0.13327927493301678
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-29-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 29 time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-29-time-from-start-28-days"
            },
            "display": "Death at or before study visit at Day 29 time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.14587332053742802
          },
          "numberOfEvents": 76,
          "sampleSize": {
            "knownDataCount": 521
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.11556329599386266
                },
                "high": {
                  "value": 0.17618334508099337
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Death-at-or-before-study-visit-at-Day-29-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Death at or before study visit at Day 29 time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Death-at-or-before-study-visit-at-Day-29-time-from-start-28-days"
            },
            "display": "Death at or before study visit at Day 29 time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": -0.03866444807901767
          },
          "numberOfEvents": 134,
          "sampleSize": {
            "knownDataCount": 1062
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": -0.07864398625818501
                },
                "high": {
                  "value": 0.0013150901001496712
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-1-time-from-start-0-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 1 time from start 0 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-1-time-from-start-0-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 1 time from start 0 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.24214417744916822
          },
          "numberOfEvents": 131,
          "sampleSize": {
            "knownDataCount": 541
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.2060457943295841
                },
                "high": {
                  "value": 0.27824256056875235
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-1-time-from-start-0-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 1 time from start 0 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-1-time-from-start-0-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 1 time from start 0 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.29558541266794625
          },
          "numberOfEvents": 154,
          "sampleSize": {
            "knownDataCount": 521
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.2564028462032998
                },
                "high": {
                  "value": 0.3347679791325927
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-1-time-from-start-0-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 1 time from start 0 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-1-time-from-start-0-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 1 time from start 0 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": -0.05344123521877803
          },
          "numberOfEvents": 285,
          "sampleSize": {
            "knownDataCount": 1062
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": -0.1067175599663121
                },
                "high": {
                  "value": -0.00016491047124395086
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-3-time-from-start-2-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 3 time from start 2 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-3-time-from-start-2-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 3 time from start 2 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.2828096118299446
          },
          "numberOfEvents": 153,
          "sampleSize": {
            "knownDataCount": 541
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.24485874046437198
                },
                "high": {
                  "value": 0.32076048319551714
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-3-time-from-start-2-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 3 time from start 2 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-3-time-from-start-2-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 3 time from start 2 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.35892514395393477
          },
          "numberOfEvents": 187,
          "sampleSize": {
            "knownDataCount": 521
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.31773497976770687
                },
                "high": {
                  "value": 0.40011530814016266
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-3-time-from-start-2-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 3 time from start 2 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-3-time-from-start-2-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 3 time from start 2 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": -0.07611553212399019
          },
          "numberOfEvents": 340,
          "sampleSize": {
            "knownDataCount": 1062
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": -0.1321235517559558
                },
                "high": {
                  "value": -0.020107512492024568
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-5-time-from-start-4-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 5 time from start 4 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-5-time-from-start-4-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 5 time from start 4 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.2809611829944547
          },
          "numberOfEvents": 152,
          "sampleSize": {
            "knownDataCount": 541
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.24308582309094806
                },
                "high": {
                  "value": 0.3188365428979614
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-5-time-from-start-4-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 5 time from start 4 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-5-time-from-start-4-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 5 time from start 4 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.3666026871401152
          },
          "numberOfEvents": 191,
          "sampleSize": {
            "knownDataCount": 521
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.32522433988510835
                },
                "high": {
                  "value": 0.407981034395122
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-5-time-from-start-4-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 5 time from start 4 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-5-time-from-start-4-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 5 time from start 4 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": -0.08564150414566046
          },
          "numberOfEvents": 343,
          "sampleSize": {
            "knownDataCount": 1062
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": -0.14173705218091986
                },
                "high": {
                  "value": -0.029545956110401075
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-8-time-from-start-7-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 8 time from start 7 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-8-time-from-start-7-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 8 time from start 7 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.24029574861367836
          },
          "numberOfEvents": 130,
          "sampleSize": {
            "knownDataCount": 541
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.2042915821655087
                },
                "high": {
                  "value": 0.27629991506184803
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-8-time-from-start-7-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 8 time from start 7 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-8-time-from-start-7-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 8 time from start 7 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.33205374280230326
          },
          "numberOfEvents": 173,
          "sampleSize": {
            "knownDataCount": 521
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.29161364847272403
                },
                "high": {
                  "value": 0.3724938371318825
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-8-time-from-start-7-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 8 time from start 7 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-8-time-from-start-7-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 8 time from start 7 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": -0.0917579941886249
          },
          "numberOfEvents": 303,
          "sampleSize": {
            "knownDataCount": 1062
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": -0.14590318077998105
                },
                "high": {
                  "value": -0.03761280759726876
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-11-time-from-start-10-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 11 time from start 10 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-11-time-from-start-10-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 11 time from start 10 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.2199630314232902
          },
          "numberOfEvents": 119,
          "sampleSize": {
            "knownDataCount": 541
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.18505785158855842
                },
                "high": {
                  "value": 0.254868211258022
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-11-time-from-start-10-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 11 time from start 10 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-11-time-from-start-10-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 11 time from start 10 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.2840690978886756
          },
          "numberOfEvents": 148,
          "sampleSize": {
            "knownDataCount": 521
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.2453446923130359
                },
                "high": {
                  "value": 0.32279350346431535
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-11-time-from-start-10-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 11 time from start 10 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-11-time-from-start-10-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 11 time from start 10 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": -0.06410606646538541
          },
          "numberOfEvents": 267,
          "sampleSize": {
            "knownDataCount": 1062
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": -0.1162400397120276
                },
                "high": {
                  "value": -0.011972093218743221
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-15-time-from-start-14-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 15 time from start 14 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-15-time-from-start-14-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 15 time from start 14 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.1534195933456562
          },
          "numberOfEvents": 83,
          "sampleSize": {
            "knownDataCount": 541
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.12305049074000482
                },
                "high": {
                  "value": 0.18378869595130756
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-15-time-from-start-14-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 15 time from start 14 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-15-time-from-start-14-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 15 time from start 14 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.22072936660268713
          },
          "numberOfEvents": 115,
          "sampleSize": {
            "knownDataCount": 521
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.18511613177557815
                },
                "high": {
                  "value": 0.25634260142979615
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-15-time-from-start-14-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 15 time from start 14 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-15-time-from-start-14-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 15 time from start 14 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": -0.06730977325703094
          },
          "numberOfEvents": 198,
          "sampleSize": {
            "knownDataCount": 1062
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": -0.114113457812025
                },
                "high": {
                  "value": -0.02050608870203688
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-22-time-from-start-21-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 22 time from start 21 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-22-time-from-start-21-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 22 time from start 21 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.09057301293900184
          },
          "numberOfEvents": 49,
          "sampleSize": {
            "knownDataCount": 541
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.06638830956665853
                },
                "high": {
                  "value": 0.11475771631134515
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-22-time-from-start-21-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 22 time from start 21 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-22-time-from-start-21-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 22 time from start 21 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.14395393474088292
          },
          "numberOfEvents": 75,
          "sampleSize": {
            "knownDataCount": 521
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.1138101661259795
                },
                "high": {
                  "value": 0.17409770335578634
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-22-time-from-start-21-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 22 time from start 21 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-22-time-from-start-21-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 22 time from start 21 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": -0.05338092180188107
          },
          "numberOfEvents": 124,
          "sampleSize": {
            "knownDataCount": 1062
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": -0.09202735324796765
                },
                "high": {
                  "value": -0.014734490355794494
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-29-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 29 time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-29-time-from-start-28-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 29 time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.05545286506469501
          },
          "numberOfEvents": 30,
          "sampleSize": {
            "knownDataCount": 541
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.0361673496039375
                },
                "high": {
                  "value": 0.07473838052545252
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-29-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 29 time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-29-time-from-start-28-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 29 time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.08637236084452975
          },
          "numberOfEvents": 45,
          "sampleSize": {
            "knownDataCount": 521
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.0622505882069533
                },
                "high": {
                  "value": 0.1104941334821062
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Invasive-Ventilation-or-ECMO-at-Day-29-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Invasive Ventilation or ECMO at Day 29 time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Invasive-Ventilation-or-ECMO-at-Day-29-time-from-start-28-days"
            },
            "display": "Invasive Ventilation or ECMO at Day 29 time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": -0.030919495779834737
          },
          "numberOfEvents": 75,
          "sampleSize": {
            "knownDataCount": 1062
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": -0.06180300305744246
                },
                "high": {
                  "value": -0.000035988502227014135
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Adverse-Events-Grade-3-or-4-at-Day-29-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Adverse Events Grade 3 or 4 at Day 29 time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Adverse-Events-Grade-3-or-4-at-Day-29-time-from-start-28-days"
            },
            "display": "Adverse Events Grade 3 or 4 at Day 29 time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.5131578947368421
          },
          "numberOfEvents": 273,
          "sampleSize": {
            "knownDataCount": 532
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.4706842208240238
                },
                "high": {
                  "value": 0.5556315686496605
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Adverse-Events-Grade-3-or-4-at-Day-29-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Adverse Events Grade 3 or 4 at Day 29 time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Adverse-Events-Grade-3-or-4-at-Day-29-time-from-start-28-days"
            },
            "display": "Adverse Events Grade 3 or 4 at Day 29 time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.5717054263565892
          },
          "numberOfEvents": 295,
          "sampleSize": {
            "knownDataCount": 516
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.5290092814504161
                },
                "high": {
                  "value": 0.6144015712627622
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Adverse-Events-Grade-3-or-4-at-Day-29-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Adverse Events Grade 3 or 4 at Day 29 time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Adverse-Events-Grade-3-or-4-at-Day-29-time-from-start-28-days"
            },
            "display": "Adverse Events Grade 3 or 4 at Day 29 time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": -0.05854753161974702
          },
          "numberOfEvents": 568,
          "sampleSize": {
            "knownDataCount": 1048
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": -0.11877189351343048
                },
                "high": {
                  "value": 0.0016768302739364471
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Serious-Adverse-Events-at-Day-29-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Serious Adverse Events at Day 29 time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Serious-Adverse-Events-at-Day-29-time-from-start-28-days"
            },
            "display": "Serious Adverse Events at Day 29 time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.24436090225563908
          },
          "numberOfEvents": 130,
          "sampleSize": {
            "knownDataCount": 532
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.20784573236273135
                },
                "high": {
                  "value": 0.2808760721485468
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Serious-Adverse-Events-at-Day-29-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Serious Adverse Events at Day 29 time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Serious-Adverse-Events-at-Day-29-time-from-start-28-days"
            },
            "display": "Serious Adverse Events at Day 29 time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.31589147286821706
          },
          "numberOfEvents": 163,
          "sampleSize": {
            "knownDataCount": 516
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.27578054819810743
                },
                "high": {
                  "value": 0.3560023975383267
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Serious-Adverse-Events-at-Day-29-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Serious Adverse Events at Day 29 time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Serious-Adverse-Events-at-Day-29-time-from-start-28-days"
            },
            "display": "Serious Adverse Events at Day 29 time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": -0.07153057061257798
          },
          "numberOfEvents": 293,
          "sampleSize": {
            "knownDataCount": 1048
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": -0.12577302548142702
                },
                "high": {
                  "value": -0.01728811574372894
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Incomplete-Dosing-Due-to-Discharge-time-from-start-9-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Incomplete Dosing Due to Discharge time from start 9 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Incomplete-Dosing-Due-to-Discharge-time-from-start-9-days"
            },
            "display": "Incomplete Dosing Due to Discharge time from start 9 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.4121996303142329
          },
          "numberOfEvents": 223,
          "sampleSize": {
            "knownDataCount": 541
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.37072083206726136
                },
                "high": {
                  "value": 0.45367842856120444
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Incomplete-Dosing-Due-to-Discharge-time-from-start-9-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Incomplete Dosing Due to Discharge time from start 9 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Incomplete-Dosing-Due-to-Discharge-time-from-start-9-days"
            },
            "display": "Incomplete Dosing Due to Discharge time from start 9 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.30326295585412666
          },
          "numberOfEvents": 158,
          "sampleSize": {
            "knownDataCount": 521
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.2637916638391438
                },
                "high": {
                  "value": 0.3427342478691095
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Incomplete-Dosing-Due-to-Discharge-time-from-start-9-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Incomplete Dosing Due to Discharge time from start 9 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Incomplete-Dosing-Due-to-Discharge-time-from-start-9-days"
            },
            "display": "Incomplete Dosing Due to Discharge time from start 9 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": 0.10893667446010624
          },
          "numberOfEvents": 381,
          "sampleSize": {
            "knownDataCount": 1062
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.05167871783096153
                },
                "high": {
                  "value": 0.16619463108925095
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Incomplete-Dosing-Due-to-Death-time-from-start-9-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Incomplete Dosing Due to Death time from start 9 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Incomplete-Dosing-Due-to-Death-time-from-start-9-days"
            },
            "display": "Incomplete Dosing Due to Death time from start 9 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.027726432532347505
          },
          "numberOfEvents": 15,
          "sampleSize": {
            "knownDataCount": 541
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.01389081094454154
                },
                "high": {
                  "value": 0.04156205412015347
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Incomplete-Dosing-Due-to-Death-time-from-start-9-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Incomplete Dosing Due to Death time from start 9 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Incomplete-Dosing-Due-to-Death-time-from-start-9-days"
            },
            "display": "Incomplete Dosing Due to Death time from start 9 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.036468330134357005
          },
          "numberOfEvents": 19,
          "sampleSize": {
            "knownDataCount": 521
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.020371952757502705
                },
                "high": {
                  "value": 0.052564707511211305
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Incomplete-Dosing-Due-to-Death-time-from-start-9-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Incomplete Dosing Due to Death time from start 9 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Incomplete-Dosing-Due-to-Death-time-from-start-9-days"
            },
            "display": "Incomplete Dosing Due to Death time from start 9 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": -0.0087418976020095
          },
          "numberOfEvents": 34,
          "sampleSize": {
            "knownDataCount": 1062
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": -0.02996730194159911
                },
                "high": {
                  "value": 0.01248350673758011
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Incomplete-Dosing-ANY-reason-time-from-start-9-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Incomplete Dosing (ANY reason) time from start 9 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Incomplete-Dosing-ANY-reason-time-from-start-9-days"
            },
            "display": "Incomplete Dosing (ANY reason) time from start 9 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.6155268022181146
          },
          "numberOfEvents": 333,
          "sampleSize": {
            "knownDataCount": 541
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.5745334005513585
                },
                "high": {
                  "value": 0.6565202038848708
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Incomplete-Dosing-ANY-reason-time-from-start-9-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Incomplete Dosing (ANY reason) time from start 9 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Incomplete-Dosing-ANY-reason-time-from-start-9-days"
            },
            "display": "Incomplete Dosing (ANY reason) time from start 9 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.5662188099808061
          },
          "numberOfEvents": 295,
          "sampleSize": {
            "knownDataCount": 521
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.5236624264751963
                },
                "high": {
                  "value": 0.6087751934864158
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Incomplete-Dosing-ANY-reason-time-from-start-9-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Incomplete Dosing (ANY reason) time from start 9 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Incomplete-Dosing-ANY-reason-time-from-start-9-days"
            },
            "display": "Incomplete Dosing (ANY reason) time from start 9 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": 0.04930799223730853
          },
          "numberOfEvents": 628,
          "sampleSize": {
            "knownDataCount": 1062
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": -0.009780964068320554
                },
                "high": {
                  "value": 0.1083969485429376
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Received-all-10-intended-doses-time-from-start-9-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Received all 10 intended doses time from start 9 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Received-all-10-intended-doses-time-from-start-9-days"
            },
            "display": "Received all 10 intended doses time from start 9 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.3844731977818854
          },
          "numberOfEvents": 208,
          "sampleSize": {
            "knownDataCount": 541
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.3434797961151292
                },
                "high": {
                  "value": 0.42546659944864157
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Received-all-10-intended-doses-time-from-start-9-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Received all 10 intended doses time from start 9 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Received-all-10-intended-doses-time-from-start-9-days"
            },
            "display": "Received all 10 intended doses time from start 9 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.43378119001919385
          },
          "numberOfEvents": 226,
          "sampleSize": {
            "knownDataCount": 521
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.3912248065135841
                },
                "high": {
                  "value": 0.4763375735248036
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Received-all-10-intended-doses-time-from-start-9-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Received all 10 intended doses time from start 9 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Received-all-10-intended-doses-time-from-start-9-days"
            },
            "display": "Received all 10 intended doses time from start 9 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": -0.04930799223730847
          },
          "numberOfEvents": 434,
          "sampleSize": {
            "knownDataCount": 1062
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": -0.10839694854293755
                },
                "high": {
                  "value": 0.00978096406832061
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Duration-of-Hospitalization-ITT-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Duration of Hospitalization/ITT time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Duration-of-Hospitalization-ITT-time-from-start-28-days"
            },
            "display": "Duration of Hospitalization/ITT time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C28007",
                "display": "Median"
              }
            ]
          },
          "quantity": {
            "value": 12,
            "unit": "days",
            "system": "http://unitsofmeasure.org/",
            "code": "d"
          },
          "sampleSize": {
            "knownDataCount": 541
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53245",
                    "display": "Interquartile range"
                  }
                ]
              },
              "range": {
                "low": {
                  "value": 6,
                  "unit": "days",
                  "system": "http://unitsofmeasure.org/",
                  "code": "d"
                },
                "high": {
                  "value": 28,
                  "unit": "days",
                  "system": "http://unitsofmeasure.org/",
                  "code": "d"
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Duration-of-Hospitalization-ITT-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Duration of Hospitalization/ITT time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Duration-of-Hospitalization-ITT-time-from-start-28-days"
            },
            "display": "Duration of Hospitalization/ITT time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C28007",
                "display": "Median"
              }
            ]
          },
          "quantity": {
            "value": 17,
            "unit": "days",
            "system": "http://unitsofmeasure.org/",
            "code": "d"
          },
          "sampleSize": {
            "knownDataCount": 521
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53245",
                    "display": "Interquartile range"
                  }
                ]
              },
              "range": {
                "low": {
                  "value": 8,
                  "unit": "days",
                  "system": "http://unitsofmeasure.org/",
                  "code": "d"
                },
                "high": {
                  "value": 28,
                  "unit": "days",
                  "system": "http://unitsofmeasure.org/",
                  "code": "d"
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Duration-of-Hospitalization-ITT-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Duration of Hospitalization/ITT time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Duration-of-Hospitalization-ITT-time-from-start-28-days"
            },
            "display": "Duration of Hospitalization/ITT time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "absolute-MedianDiff",
                "display": "Absolute Median Difference"
              }
            ]
          },
          "quantity": {
            "value": -5,
            "unit": "days",
            "system": "http://unitsofmeasure.org/",
            "code": "d"
          },
          "sampleSize": {
            "knownDataCount": 1062
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Duration-of-Hospitalization-Survivors-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Duration of Hospitalization/Survivors time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Duration-of-Hospitalization-Survivors-time-from-start-28-days"
            },
            "display": "Duration of Hospitalization/Survivors time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C28007",
                "display": "Median"
              }
            ]
          },
          "quantity": {
            "value": 10,
            "unit": "days",
            "system": "http://unitsofmeasure.org/",
            "code": "d"
          },
          "sampleSize": {
            "knownDataCount": 480
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53245",
                    "display": "Interquartile range"
                  }
                ]
              },
              "range": {
                "low": {
                  "value": 5,
                  "unit": "days",
                  "system": "http://unitsofmeasure.org/",
                  "code": "d"
                },
                "high": {
                  "value": 21,
                  "unit": "days",
                  "system": "http://unitsofmeasure.org/",
                  "code": "d"
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Duration-of-Hospitalization-Survivors-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Duration of Hospitalization/Survivors time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Duration-of-Hospitalization-Survivors-time-from-start-28-days"
            },
            "display": "Duration of Hospitalization/Survivors time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C28007",
                "display": "Median"
              }
            ]
          },
          "quantity": {
            "value": 14,
            "unit": "days",
            "system": "http://unitsofmeasure.org/",
            "code": "d"
          },
          "sampleSize": {
            "knownDataCount": 443
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53245",
                    "display": "Interquartile range"
                  }
                ]
              },
              "range": {
                "low": {
                  "value": 7,
                  "unit": "days",
                  "system": "http://unitsofmeasure.org/",
                  "code": "d"
                },
                "high": {
                  "value": 27,
                  "unit": "days",
                  "system": "http://unitsofmeasure.org/",
                  "code": "d"
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Duration-of-Hospitalization-Survivors-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Duration of Hospitalization/Survivors time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Duration-of-Hospitalization-Survivors-time-from-start-28-days"
            },
            "display": "Duration of Hospitalization/Survivors time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "absolute-MedianDiff",
                "display": "Absolute Median Difference"
              }
            ]
          },
          "quantity": {
            "value": -4,
            "unit": "days",
            "system": "http://unitsofmeasure.org/",
            "code": "d"
          },
          "sampleSize": {
            "knownDataCount": 923
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Duration-of-New-Ventilator-ECMO-Use-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Duration of New Ventilator/ECMO Use time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Duration-of-New-Ventilator-ECMO-Use-time-from-start-28-days"
            },
            "display": "Duration of New Ventilator/ECMO Use time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C28007",
                "display": "Median"
              }
            ]
          },
          "quantity": {
            "value": 21.5,
            "unit": "days",
            "system": "http://unitsofmeasure.org/",
            "code": "d"
          },
          "sampleSize": {
            "knownDataCount": 52
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53245",
                    "display": "Interquartile range"
                  }
                ]
              },
              "range": {
                "low": {
                  "value": 9,
                  "unit": "days",
                  "system": "http://unitsofmeasure.org/",
                  "code": "d"
                },
                "high": {
                  "value": 28,
                  "unit": "days",
                  "system": "http://unitsofmeasure.org/",
                  "code": "d"
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Duration-of-New-Ventilator-ECMO-Use-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Duration of New Ventilator/ECMO Use time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Duration-of-New-Ventilator-ECMO-Use-time-from-start-28-days"
            },
            "display": "Duration of New Ventilator/ECMO Use time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C28007",
                "display": "Median"
              }
            ]
          },
          "quantity": {
            "value": 23,
            "unit": "days",
            "system": "http://unitsofmeasure.org/",
            "code": "d"
          },
          "sampleSize": {
            "knownDataCount": 82
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53245",
                    "display": "Interquartile range"
                  }
                ]
              },
              "range": {
                "low": {
                  "value": 12,
                  "unit": "days",
                  "system": "http://unitsofmeasure.org/",
                  "code": "d"
                },
                "high": {
                  "value": 28,
                  "unit": "days",
                  "system": "http://unitsofmeasure.org/",
                  "code": "d"
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Duration-of-New-Ventilator-ECMO-Use-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Duration of New Ventilator/ECMO Use time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Duration-of-New-Ventilator-ECMO-Use-time-from-start-28-days"
            },
            "display": "Duration of New Ventilator/ECMO Use time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "absolute-MedianDiff",
                "display": "Absolute Median Difference"
              }
            ]
          },
          "quantity": {
            "value": -1.5,
            "unit": "days",
            "system": "http://unitsofmeasure.org/",
            "code": "d"
          },
          "sampleSize": {
            "knownDataCount": 134
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Duration-of-New-Ventilator-ECMO-Use-Survivors-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Duration of New Ventilator/ECMO Use (Survivors) time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Duration-of-New-Ventilator-ECMO-Use-Survivors-time-from-start-28-days"
            },
            "display": "Duration of New Ventilator/ECMO Use (Survivors) time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C28007",
                "display": "Median"
              }
            ]
          },
          "quantity": {
            "value": 14,
            "unit": "days",
            "system": "http://unitsofmeasure.org/",
            "code": "d"
          },
          "sampleSize": {
            "knownDataCount": 39
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53245",
                    "display": "Interquartile range"
                  }
                ]
              },
              "range": {
                "low": {
                  "value": 5,
                  "unit": "days",
                  "system": "http://unitsofmeasure.org/",
                  "code": "d"
                },
                "high": {
                  "value": 26,
                  "unit": "days",
                  "system": "http://unitsofmeasure.org/",
                  "code": "d"
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Duration-of-New-Ventilator-ECMO-Use-Survivors-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Duration of New Ventilator/ECMO Use (Survivors) time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Duration-of-New-Ventilator-ECMO-Use-Survivors-time-from-start-28-days"
            },
            "display": "Duration of New Ventilator/ECMO Use (Survivors) time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C28007",
                "display": "Median"
              }
            ]
          },
          "quantity": {
            "value": 16,
            "unit": "days",
            "system": "http://unitsofmeasure.org/",
            "code": "d"
          },
          "sampleSize": {
            "knownDataCount": 57
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53245",
                    "display": "Interquartile range"
                  }
                ]
              },
              "range": {
                "low": {
                  "value": 9,
                  "unit": "days",
                  "system": "http://unitsofmeasure.org/",
                  "code": "d"
                },
                "high": {
                  "value": 24,
                  "unit": "days",
                  "system": "http://unitsofmeasure.org/",
                  "code": "d"
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "Duration-of-New-Ventilator-ECMO-Use-Survivors-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "Duration of New Ventilator/ECMO Use (Survivors) time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Duration-of-New-Ventilator-ECMO-Use-Survivors-time-from-start-28-days"
            },
            "display": "Duration of New Ventilator/ECMO Use (Survivors) time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "absolute-MedianDiff",
                "display": "Absolute Median Difference"
              }
            ]
          },
          "quantity": {
            "value": -2,
            "unit": "days",
            "system": "http://unitsofmeasure.org/",
            "code": "d"
          },
          "sampleSize": {
            "knownDataCount": 96
          }
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "New-Ventilator-or-ECMO-Use-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "New Ventilator or ECMO Use time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "New-Ventilator-or-ECMO-Use-time-from-start-28-days"
            },
            "display": "New Ventilator or ECMO Use time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.12935323383084577
          },
          "numberOfEvents": 52,
          "sampleSize": {
            "knownDataCount": 402
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.09654727876394065
                },
                "high": {
                  "value": 0.16215918889775088
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "New-Ventilator-or-ECMO-Use-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "New Ventilator or ECMO Use time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "New-Ventilator-or-ECMO-Use-time-from-start-28-days"
            },
            "display": "New Ventilator or ECMO Use time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.22527472527472528
          },
          "numberOfEvents": 82,
          "sampleSize": {
            "knownDataCount": 364
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.18235712048260766
                },
                "high": {
                  "value": 0.2681923300668429
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "New-Ventilator-or-ECMO-Use-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "New Ventilator or ECMO Use time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "New-Ventilator-or-ECMO-Use-time-from-start-28-days"
            },
            "display": "New Ventilator or ECMO Use time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": -0.09592149144387951
          },
          "numberOfEvents": 134,
          "sampleSize": {
            "knownDataCount": 766
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": -0.14994140896458846
                },
                "high": {
                  "value": -0.04190157392317057
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "14-day-Mortality-time-from-start-14-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "14-day Mortality time from start 14 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "14-day-Mortality-time-from-start-14-days"
            },
            "display": "14-day Mortality time from start 14 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.06469500924214418
          },
          "numberOfEvents": 35,
          "sampleSize": {
            "knownDataCount": 541
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.04396643390606148
                },
                "high": {
                  "value": 0.08542358457822688
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "14-day-Mortality-time-from-start-14-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "14-day Mortality time from start 14 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "14-day-Mortality-time-from-start-14-days"
            },
            "display": "14-day Mortality time from start 14 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.11708253358925144
          },
          "numberOfEvents": 61,
          "sampleSize": {
            "knownDataCount": 521
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.08947400128456866
                },
                "high": {
                  "value": 0.1446910658939342
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "14-day-Mortality-time-from-start-14-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "14-day Mortality time from start 14 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "14-day-Mortality-time-from-start-14-days"
            },
            "display": "14-day Mortality time from start 14 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": -0.052387524347107264
          },
          "numberOfEvents": 96,
          "sampleSize": {
            "knownDataCount": 1062
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": -0.08691149995077099
                },
                "high": {
                  "value": -0.01786354874344353
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "28-day-Mortality-time-from-start-28-days-for-Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "28-day Mortality time from start 28 days for Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Remdesivir-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Remdesivir Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "28-day-Mortality-time-from-start-28-days"
            },
            "display": "28-day Mortality time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.10905730129390019
          },
          "numberOfEvents": 59,
          "sampleSize": {
            "knownDataCount": 541
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.08279034819457265
                },
                "high": {
                  "value": 0.13532425439322773
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "28-day-Mortality-time-from-start-28-days-for-Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "28-day Mortality time from start 28 days for Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "subpopulation",
                "display": "subpopulation"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Placebo-Cohort-in-Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Placebo Cohort in Adaptive COVID-19 Treatment Trial (ACTT) participants"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "28-day-Mortality-time-from-start-28-days"
            },
            "display": "28-day Mortality time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "C44256",
                "display": "Proportion"
              }
            ]
          },
          "quantity": {
            "value": 0.14779270633397312
          },
          "numberOfEvents": 77,
          "sampleSize": {
            "knownDataCount": 521
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": 0.11731822421044305
                },
                "high": {
                  "value": 0.1782671884575032
                }
              }
            }
          ]
        }
      ]
    },
    {
      "resourceType": "Evidence",
      "id": "28-day-Mortality-time-from-start-28-days-for-Remdesivir-vs-Placebo-in-Adaptive-COVID-19-Treatment-Trial-ACTT",
      "title": "28-day Mortality time from start 28 days for Remdesivir vs Placebo in Adaptive COVID-19 Treatment Trial (ACTT)",
      "status": "draft",
      "variableDefinition": [
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "population",
                "display": "population"
              }
            ]
          },
          "observed": {
            "type": "Group",
            "identifier": {
              "value": "Adaptive-COVID-19-Treatment-Trial-ACTT-participants"
            },
            "display": "Adaptive COVID-19 Treatment Trial (ACTT) participants"
          },
          "intended": {
            "type": "Group",
            "identifier": {
              "value": "COVID-19"
            },
            "display": "COVID-19"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "exposure",
                "display": "exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Remdesivir"
            },
            "display": "Remdesivir"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "referenceExposure",
                "display": "reference exposure"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "Placebo"
            },
            "display": "Placebo"
          }
        },
        {
          "variableRole": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/variable-role",
                "code": "measuredVariable",
                "display": "measured variable"
              }
            ]
          },
          "observed": {
            "type": "EvidenceVariable",
            "identifier": {
              "value": "28-day-Mortality-time-from-start-28-days"
            },
            "display": "28-day Mortality time from start 28 days"
          }
        }
      ],
      "studyType": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/study-type",
            "code": "RCT",
            "display": "randomized trial"
          }
        ]
      },
      "statistic": [
        {
          "statisticType": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/statistic-type",
                "code": "0000424",
                "display": "Risk Difference"
              }
            ]
          },
          "quantity": {
            "value": -0.03873540504007293
          },
          "numberOfEvents": 136,
          "sampleSize": {
            "knownDataCount": 1062
          },
          "attributeEstimate": [
            {
              "type": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type",
                    "code": "C53324",
                    "display": "Confidence interval"
                  }
                ]
              },
              "level": 0.95,
              "range": {
                "low": {
                  "value": -0.07896781592756047
                },
                "high": {
                  "value": 0.0014970058474146133
                }
              }
            }
          ]
        }
      ]
    }
  ]
}